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The insulin/IGF-like signaling cascade and stress response pathways are conserved 
throughout the animal kingdom and known to modulate a wide-range of biological 
processes to cope with environmental cues or stress. Previous studies have suggested 
that the insulin/IGF-like signaling and stress response are functionally linked and may 
play an integral role in controlling aging and longevity. However, our understanding 
regarding the underlying molecular mechanisms of the cross-talks between the 
insulin/IGF-like signaling and stress response pathways are incomplete. Thus, in this 
study, we aimed to further elucidate the cross-talks between these evolutionally 
conserved biological pathways by studying novel regulators of these pathways. 
 
We demonstrated two potential mechanisms that mediate the cross-talk between 
insulin/IGF-like signaling and stress response. (1) We found that the activity of HSF-1 is 
regulated by insulin/IGF-like signaling pathway via two novel HSF-1 regulators, DDL-1 
and DDL-2.  DDL-1 and -2 negatively regulate HSF-1 activity by forming a protein 
complex with HSF-1, and the formation of this complex (DHIC) is modulated by the 
activity of insulin/IGF-like signaling. These data suggested a role for DDL-1 and DDL-2 in 
insulin/IGF-like signaling-mediated HSF-1 regulation. (2) We also demonstrated that C. 
elegans SIR-2.4 is required for the cellular responses to multiple stressors and promotes 
stress-induced DAF-16 (FoxO transcription factor) activation. Although SIR-2.4 is a 
member of the sirtuin deacetylase family, the catalytic activity of SIR-2.4 is dispensable 
for modulating DAF-16 nuclear translocation. We found that SIR-2.4 regulates DAF-16 
function by preventing CBP-1-mediated acetylation, possibly via protein-protein 
interaction. Overall, our work presented in this study has provided a broader 
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understanding of potential mechanisms that the link insulin/IGF-like signaling pathway 









Chapter 1.  Introduction 
 
1-1 Aging 
In most advanced countries, the increasing costs of a growing elderly population on a 
health care system have challenged the society. For example, in the U.S., the older 
population (65 years or older) was 39.6 million in 2009. In 2030, this number is projected 
to be 72.1 million, twice as many as in 2009. The health care of senior citizens has 
gradually become a serious social concern.  
 
Aging is a fundamental biological process defined as gradual changes made to cells and 
tissues that eventually lead to biological impairment. These changes have a direct 
impact on the function of organs, biological systems, and ultimately, the organism. These 
changes adversely affect the vitality and increase the mortality rate as a function of time. 
Age-related deterioration in an organism was previously considered as simply 
wear-and-tear on tissues and organs. Aging was not thought to be an actively regulated 
biological process until the past decade. Recent studies have pointed out that similar to 
many other biological processes, aging is subjected to regulation by evolutionally 
conserved genes and signaling pathways. Understanding the biology of aging is an 
important first step toward developing future pharmacological interventions that could 
ameliorate various age-related disorders, delay the normal aging process, and promote 




1-2 C. elegans as an aging model organism 
Aging has always been one of the biological phenomena of greatest interest to mankind. 
The recent advancement of genetic, molecular biological, and biochemical tools allow us 
to explore in detail the underlying mechanisms of many biological processes. However, 
the study of longevity in humans remains difficult because a longitudinal study of 
longevity of a human population would take more than one generation to complete. 
Moreover, the genetic background among the human population is highly heterogeneous, 
making it difficult to assess the genetic interactions of longevity genes. Thus, using 
model organisms to study aging is an excellent alternative. 
 
Complex biological phenomena, such as aging, disease and behavior, appear only in 
multi-cellular life forms. Therefore, to study the biological process of aging, an ideal 
model organism has to be complex enough to address higher-order questions that are 
relevant to human physiology, but simple enough to manipulate. Caenorhabditis elegans 
is a free-living, soil-dwelling nematode naturally found in nutrient or bacterial-rich 
environments, where they feed on rotting organic matter as well as on a variety of 
microbes including bacteria and fungus. C. elegans has emerged as an ideal model 
organism for studying molecular genetics of aging because of its transparency, 
well-defined anatomy, short lifespan (~20 days), and ease of genetic manipulation. 
Experimentally, the manipulation of worms is far simpler than many other systems such 
as primates, rodents, zebrafish, and even mammalian cells: The maintenance of C. 
elegans culture does not require specialized techniques or equipments; worms can 
easily grow at room temperature in unmodified air; manipulation of C. elegans does not 
require an extensively sterilized environment; and the contamination of worm culture can 
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be easily removed.  
 
C. elegans is genetically tractable. The genome is fully sequenced and the knockdown of 
any gene can be easily accomplished by feeding E. coli expressing double-strand RNA 
on the gene of interest. It is the first model organism found in which lifespan can be 
altered by a single gene mutation. Many fundamental biological processes found in 
worms and mammals are homologous [5,6]. Moreover, C. elegans shares similar 
characteristics of aging with mammals, including sarcopenia, lipofucin accumulation, 
reduced cuticle elasticity, and susceptibility to infection [7-9]. As such, studying the 
biological process of aging in worms could provide invaluable insights into mammalian 
aging, as well as many age-related diseases, such as macular degeneration, cataracts, 
Alzheimer’s disease, and Parkinson’s disease. 
 
1-3 The role of the insulin/IGF-like signaling pathway in longevity regulation 
Genetic analysis in C. elegans has revealed many longevity genes and pathways. The 
best-characterized longevity signaling pathway is the insulin/IGF-like signaling cascade. 
The insulin/IGF-like signaling pathway is conserved throughout the animal kingdom and 
has been shown to regulate lifespan in a wide range of species [10]. Mutations of 
insulin/IGF-like signaling components are known to affect longevity. For instance, 
mutation of daf-2, an insulin/IGF-like receptor, was found to double the lifespan of 
animals [11,12]. In flies, a mutation of the insulin/IGF-1 receptor also increases lifespan 
by ~80% [10]. Additionally, a mutation of chico, an insulin receptor substrate (IRS)-like 
gene, has also been shown to extend lifespan by ~40% [13,14]. In mice, an 
adipocyte-specific insulin receptor knock-out (FIRKO) increases lifespan by 18% [15]. 
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Furthermore, IGF-1 heterozygous knock-out female animals live 30% longer than 
wild-types, while male animals live 16% longer [16]. In addition, mutations of upstream 
genes that regulate insulin/IGF-1 production also extend lifespan. Mice with a growth 
hormone receptor deletion or pituitary defect, which results in a severe decrease in 
insulin and IGF-1 levels, are also long-lived [17,18]. In humans, centenarians were found 
to have IGF-1 receptor mutations and reduced IGF-1 signaling, suggesting a potential 
role for the insulin/IGF-like signaling in modulation of human lifespan [19]. An Ecuadorian 
cohort with GHR deficiency (GHRD), which results in IGF-1 deficiency, was reported to 
have low incidence of age-related pathologies such as cancer and diabetes. [20]. Taken 
together, these lines of evidence show that the regulation of lifespan through the 
insulin/IGF-like signaling pathway is an evolutionally conserved biological process from 







Figure 1. The insulin/IGF-like signaling is conserved among species. 
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The components of the insulin/IGF-like signaling in C. elegans are very similar to those 
in higher organisms (Figure 2). This signaling pathway is initiated by the binding of 
putative insulin-like ligands to DAF-2, a homolog of mammalian insulin/IGF-like receptor 
[11,12]. In C. elegans, at least forty putative insulin-like peptides are encoded in the 
genome [21,22]. Only a few insulin-like peptides have been characterized in detail. 
Worm insulin-like peptides are expressed primarily in neurons, although a few are also 
expressed in the intestine [21-24]. These peptides act as either DAF-2 agonists (such as 
ins-7 and daf-28) or antagonists (ins-1 and ins-18). DAF-2 activates a signaling cascade 
almost identical to mammalian PI-3 kinase-AKT pathway [25-29] and promotes the 
phosphorylation of downstream protein DAF-16, a member of the FoxO (Forkhead box O) 
transcription factor family. Phosphorylated DAF-16 is prevented from entering the 
nucleus and therefore is unable to activate the expression of its target genes [30,31]. On 
the contrary, when the insulin/IGF-like signaling is reduced, DAF-16 becomes 
hypophosphorylated and translocates into the nucleus. Thus, insulin/IGF-like signaling 
negatively regulates DAF-16/FoxO, at least in part, by modulating its intracellular 
localization. FoxO transcription factors are present in all eukaryotes and are known to 
regulate many biological processes. In mammals, there are four FoxO isoforms, 
including FoxO1, FoxO3A, FoxO4, and FoxO6. In general, all FoxO isoforms have 
similar organismal functions, including apoptosis, cell cycle arrest, oxidative defense, 
DNA repair, metabolism, differentiation, stem cell function, and tumor suppression [32]. 
FoxO transcription factors display distinct but overlapping expression pattern during 
adulthood and development [33-36]. During mouse development, FoxO1 is primarily 
expressed in adipose tissues, FoxO3A is present in liver, FoxO4 can be detected in 
skeletal muscle, and FoxO6 is found in the central nervous system. In adult mice, FoxO1 
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is present in many tissues at a lower level, but highly expressed in adipose tissues, 
uterus and ovaries. FoxO3A is ubiquitously expressed; however, higher expression 
levels can be found in the heart, ovaries, spleen, and brain. FoxO4 is found primarily in 
adipose tissue, skeletal muscle, and cardiac muscle. FoxO6 is present almost 
exclusively in brain tissue [37]. Overall, these observations indicate that the activity of 
FoxOs may be differentially regulated in specific tissue, and the expression pattern of 





Figure 2. The insulin/IGF-like signaling in C. elegans. 
DAF-2 encodes the only member of the insulin/IGF-like receptor, which is 
activated upon binding of insulin-like peptide agonist. DAF-2 initiates a 
signaling cascade analogous to mammalian PI3-kinase-AKT signaling that 
leads to inhibitory phosphorylation on DAF-16, thereby attenuating DAF-16 




In C. elegans and flies, an increase in FoxO activity promotes longevity, fat storage, 
immunity, and stress resistance [32,38]. DAF-16 directs the transcription program that 
controls energy metabolism, innate immunity, and stress resistance in worms [39,40]. 
DAF-16 is required for reduction-of-function mutations of genes in the insulin/IGF-like 
signaling to extend lifespan [30,31]. In mammals, it is not clear whether FoxO is required 
for the insulin/IGF-like signaling to influence longevity, but it has been shown that FoxO 
functions via insulin/IGF-like signaling to regulate metabolism and stress resistance in 
some long-lived mice [41].  
 
1-4 FoxOs are regulated by many types of post-translational modification 
FoxOs are tightly controlled by the insulin/IGF-like signaling pathway, a major pathway 
that influences longevity. Insulin/IGF-like signaling promotes FoxO phosphorylation and 
cytoplasmic sequestration in a complex with 14-3-3 chaperones. Conversely, stress 
stimuli promote nuclear translocation of FoxO by mechanisms including activation of 
stress kinases that phosphorylate FoxO proteins on residues distinct from those 
phosphorylated in the insulin/IGF-like signaling [38]. In response to oxidative stress, 
mammalian FoxO proteins are acetylated [42-45], mono-ubiquitylated [46], 
phosphorylated [47-50] or methylated [51]. These post-translational modifications 
modulate FoxO activity in response to various stimuli to promote stress responses, cell 
death, or metabolism. 
 
1-5 Sirtuins 
Sirtuins were originally identified in yeast as Sir2 (Silent Information Regulator 2), a 
multifunctional protein that mediates telomeric gene expression, homologous end joining, 
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and gene silencing in specific genomic regions. Sirtuins are evolutionally conserved 
proteins that possess NAD+-dependent histone deacetylase activity. In mammals, the 
sirtuin family is comprised of seven members (SIRT1-7) that share a common sirtuin 
core domain but vary in tissue expression pattern, subcellular localization, substrate 
specificity and enzyme activity [4] (Figure 3). The regulation of protein function by 
acetylation has emerged as a significant post-translational regulatory mechanism. 
Similar to protein phosphorylation, acetylation status can affect many protein functions 
such as DNA binding, transcriptional activity, protein stability, localization, and enzyme 
activity [52]. Certain isoforms of sirtuins are known to catalyze the removal of acetyl 
groups from lysine residues. Unlike many other histone deacetylases, the activity of 
sirtuins requires NAD+, a substrate whose concentration is determined by the energy 
state of the cell. The dependence on NAD+ has been shown to link sirtuin activity to the 
ratio of NAD+/NADH, which controls adaptive response to energy state by modulating 
the activity of sirtuin and consequently their downstream effectors [53]. The NAD+ 
dependence of sirtuins may be important for their ability to link caloric or dietary 
restriction to longevity. Overall, this class of protein is known to regulate transcription 
factors, cofactors, histones and many other chromatin proteins. Sirtuins are implicated in 






1-6 Sirtuins modulate FoxO activity 
It has been reported that an increase of sirtuin gene dosage may promote longevity in 
yeast, flies, worms, and mice [55-58], although the role of sirtuins in lifespan regulation in 
worms and flies is controversial [59]. In mammals, SIRT1 is shown to directly deaceylate 
FoxO in response to oxidative stress [60]. SIRT2 also deacetylates FoxO to promote 
adipocyte differentiation and regulates the level of reactive oxygen species [61,62]. 
Deacetylation of FoxO by SIRT1 and SIRT2 promotes FoxO nuclear translocation 
[43,61]. Acetylation of FoxO1 has been reported to attenuate DNA binding, promote 
AKT-mediated FoxO1 phosphorylation, and direct FoxO1 to nuclear PML (promyelocytic 
leukemia) bodies [45,63]. The mitochondrial SIRT3 has been proposed to modulate 
FoxO function [64,65]. 
 
1-7 Heat-shock transcription factor (HSF) is a key factor that regulates aging 
DAF-16/FoxO is required for the insulin/IGF-like signaling pathway to modulate longevity. 
 
Figure 3. Mammalian sirtuins.   
Mammals possess seven sirtuins (SIRT1-7) that share a core sirtuin core domain (in red) and 
are shown to occupy different subcellular compartments such as nucleus (N), cytoplasm (C), 
the mitochondria (M) and nucleolus (Nucl.). 
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However, very little is known about the contributions of other transcription factors in 
insulin/IGF-like signaling-dependent longevity. One of the transcription factors recently 
shown to promote longevity in worms is heat shock factor (HSF), a leucine-zipper 
transcription factor previously known to function in the cellular response against various 
stresses [66,67]. Overexpression of HSF-1 in C. elegans is reported to promote longevity, 
whereas knockdown of hsf-1 shortens lifespan [2,68]. Four HSF isoforms have been 
identified in vertebrates: HSF1, HSF2 and HSF4 are ubiquitously expressed, whereas 
HSF3 is only found in avian species [69]. Across species, HSFs share a conservative 
N-terminal helix-turn-helix domain [70-72], an internal hydrophobic domain required for 
oligomerization, [73-75] and a carboxyl terminal transactivation domain (Figure 4) 
[76-79]. Interestingly, mammalian HSF4 lacks carboxyl terminal transactivation domain, 
suggesting that HSF4 may be involved in the negative regulation of DNA binding activity 
of other HSF isoforms. 
 
HSF regulates the expression of a group of heat-shock proteins in response to various 
stress or pathological conditions. Upon activation, HSF oligomerizes, translocates into 
the nucleus, binds to a pentanucleotide DNA motif (5’-nGAAn-3‘) known as heat-shock 
 
 
Figure 4. Mammalian HSFs 
Mammals possess three heat shock factor isoforms (HSF1, 2, 4) 
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element (HSE), and drives the expression of target genes, including molecular 
chaperone heat-shock protein 70 and 90 (hsp70 and hsp90) and a subset of small 
heat-shock proteins (shsps), to maintain protein homeostasis [80]. Under normal 
conditions, HSF is repressed in an inert monomeric state by forming an inhibitory 
complex associated with HSP40/70 and HSP90/p23. Upon heat stress, HSP40/70 and 
HSP90/p23 interact with aberrant aggregates and unfolded proteins, thereby relieving 
HSF from the inhibitory complex. Once a sufficient amount of HSPs are produced to act 
upon unfolded or misfolded proteins, excessive HSP40/70 and HSP90/p23 will again 










Figure 6. Known positive and negative regulators of HSF 
 
Additional mechanisms are known to mediate stress-induced HSF activation. Several 
genes were reported to positively or negatively regulate HSF activity through a 
stress-dependent manner, including eEF1A (translation elongation factor), HSR1 (heat 
shock RNA 1), DAXX (death domain associated protein 6), CHIP (C-terminus of 
HSP70-interacting protein), and HSBP1 (heat-shock factor binding protein 1) (Figure 6). 
Translation elongation factor eEF1A was shown to collaborate with HSR1 to activate 
HSF1 in a stress-dependent 
manner. Interestingly, in 
addition to its canonical role 
in mRNA translation, eEF1A 
is also a key component of 
actin cytoskeleton 
organization. It has been 
speculated that the collapse 
of cytoskeleton and the 
shutdown of protein 
synthesis during heat stress 
may release eEF1A, thereby 
promoting HSF1 activation 
[81]. HSR1 encodes a highly conserved non-coding RNA required for heat-shock 
response. It has been hypothesized that HSR1 may function as a cellular RNA 
thermometer that alters its secondary structure in a temperature-dependent manner [81]. 
DAXX, a protein formerly known as a modulator of apoptosis and a repressor of basal 
 
 13
transcription, is found to interact with trimeric HSF1 upon stress and enhance HSF1 
transactivation competence. It has been suggested that DAXX may promote HSF 
transactivation through relieving HSF1 from multi-chaperone complex [82]. Moreover, a 
co-chaperone has been shown to be important for HSF activation. CHIP (C-terminus of 
HSP70-interacting protein) was shown to promote HSF1 oligomerization and nuclear 
import [83]. Animals lacking CHIP are temperature-sensitive and develop apoptosis in 
multiple organs, indicating that CHIP plays a crucial role in heat-shock response. Finally, 
HSF1 activity is subject to negative regulation by HSBP1 (heat-shock factor binding 
protein 1). HSBP1 negatively affects HSF1 DNA binding activity and was shown to play a 
role in HSF1 attenuation after heat-shock [84]. Overall, these findings indicate that the 
activity of HSF is controlled at different steps of HSF activation by multiple regulators. 
 
1-8 Modulation HSF activity by post-translational modification 
Various types of post-translational modifications (PTMs) are known to promote or 
attenuate transactivation potential of HSF, thereby fine-tuning the expression of many 
stress-responsive genes. So far, twenty-one serine/threonine phosphorylation sites were 
identified on human HSF1. Most of these phosphorylation sites are heat-inducible [85]. It 
has been reported that some of these residues modulate different levels of HSF 
activation, including nuclear translocation, DNA binding activity, or transcriptional activity. 
 
In humans, phosphorylation on S307 by ERK inhibits HSF1 activity and prevents HSF1 
oligomerization [86]. S307 phosphorylation leads to a subsequent inhibitory 
phosphorylation on S303 by glycogen synthase kinase 3 (GSK3). S303 is required for 
the binding of HSF1 to signaling protein 14-3-3 epsilon to achieve transcriptional 
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repression and cytoplasmic sequestration of HSF1 after heat-shock [87]. S230 
phosphorylation promotes HSF1 transcriptional activity and is controlled by 
calcium/calmodulin-dependent protein kinase II (CaMKII) [88]. Phosphorylation of HSF1 
by mitogen-activated protein kinase (MAPK)-activated protein kinase 2 on serine 121 
inhibits HSF1 transcriptional activity and promotes HSP90 binding [89]. It has been 
suggested that T142 phosphorylation by kinase CK2 is involved in promoting 
transcriptional activity and DNA binding activity of HSF1 [90]. Acetylation status was 
implicated in regulating HSF activity. Overexpression of SIRT1, a histone deacetylase, 
promotes HSF1 DNA binding by maintaining HSF1 in a deacetylated form. Acetylation on 
lysine 80 has been shown to negatively regulate HSF1 DNA binding activity [91]. 
Stress-dependent modification by the ubiquitin-like protein SUMO-1 on lysine 298 has 






1-9 Interaction between insulin/IGF-like signaling and stress response 
pathways 
Reduction of insulin/IGF-like signaling occurs in response to unfavorable and adverse 
environmental conditions. It shifts physiological balance to a status that promotes cell 
maintenance and survival by activating the expression of many stress response genes, 
including heat shock proteins, innate immunity genes, and detoxifying genes. In addition 
to the role as a major downstream effector of the DAF-2 pathway, DAF-16 activity is also 
subject to regulation by many parallel mechanisms. Several stress-related signaling 
pathways have been shown to regulate stress-induced FoxO/DAF-16 activation (Figure 
8) [47,49,93]. For instance, c-Jun N-terminal kinase (JNK) is a positive regulator of 
DAF-16 upon stress induction [49]. It has been previously reported that oxidative stress 
 
 
Figure 7. Examples of known stress-dependent regulation of HSF 
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activates protein kinase MST1, which in turn phosphorylates FoxO, disrupts the 
interaction with 14-3-3, and promotes FoxO nuclear translocation [47]. Under stress 
conditions, B55α regulatory subunit of protein phosphatase 2A (PP2A) dephosphorylates 
FoxO1 and promotes FoxO1 nuclear import. [93]. FoxO can also be modulated by other 
stress-induced PTMs including acetylation [42-45], mono-ubiquitylation [46], and 
methylation [51,94]. However, our understanding on how stress-induced FoxO/DAF-16 




Activation of HSF-1 promotes thermotolerance and longevity in C. elegans in a 
daf-16-dependent manner. Similar to daf-16, hsf-1 is also required for the insulin/IGF-like 
signaling-mediated lifespan extension [2]. Gene expression analysis has shown that the 
proper expression of a subset of longevity genes in the DAF-2 pathway requires both 
HSF-1 and DAF-16. Moreover, potential DAF-16 and HSF-1 binding sites have been 
found to be located upstream of these genes [2]. This points to the possibility that both 
transcription factors may function together downstream of the insulin/IGF-like signaling 
pathway to promote longevity. However, the cross-talk between HSF-1 and the 
insulin/IGF-like signaling pathway is largely unclear, and the underlying mechanism by 
 
 
Figure 8. Examples of stress-dependent regulation of DAF-16/FoxO
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which the insulin/IGF-like signaling cascade regulates HSF-1 has not been established.  
 
The insulin/IGF-like signaling and stress response pathways are functionally linked; 
however, the interaction between these pathways is not well understood. Therefore, in 
this thesis, we aim to further explore the interaction between the insulin/IGF-like 
signaling and stress response pathways by examining the roles of genes that mediate 
the cross-talk between the insulin/IGF-like signaling and stress response pathways 
(Figure 9). This study will provide deeper understanding of the potential molecular 
mechanisms that link these pathways.  
 
Despite the fact that the insulin/IGF signaling and stress response pathways have been 
found to intertwined, the physiological significance of the cross-talk at organismal level 
remains elusive. C. elegans is a unique and powerful tool to study the functional role and 
systemic regulation of longevity and stress resistance, as similar studies in mammals 
can be laborious and extremely expensive. Since the components of many key biological 
processes (including insulin/IGF-like signaling and heat-shock response) in mammals 
and C. elegans are largely homologous, the cross-talks between these pathways may be 
important for coordinating proper downstream gene expression in specifying optimum 
longevity and stress resistance in higher organisms. Thus, findings obtained in C. 
elegans would provide important insights into how insulin/IGF-like signaling and stress 
response pathways coordinately regulate longevity in humans. Our study presented here 
will shed light on the mechanisms by which the aging process and stress response are 
controlled. It may identify potential future targets for therapeutic intervention to increase 







Figure 9. Potential cross-talk between insulin/IGF-like signaling and stress response pathways. 





Chapter 2.  HSF-1 regulators DDL-1/2 link insulin-like signaling to 
heat-shock responses and modulation of longevity.* 
 
2-1 Abstract 
The most prominent longevity signaling pathway in C. elegans is the insulin/IGF-like 
signaling pathway. A reduction in the insulin/IGF-like signaling pathway extends lifespan 
in C. elegans. DAF-16, a member of the FoxO (Forkhead box O) transcription factor 
family, is required for the reduction-of-function mutations in the insulin/IGF-like signaling 
pathway to promote longevity and stress resistance. However, very little is known about 
the contributions of other transcription factors in the context of insulin/IGF-like 
signaling-mediated longevity. 
 
One of the transcription factor that regulates longevity is heat shock factor-1 (HSF-1), a 
protein previously known to be involved in cellular survival against various stresses. An 
elevated level of HSF-1 increases thermotolerance and longevity in C. elegans. HSF-1 is 
also known to be required for the insulin/IGF-like signaling-mediated longevity in worms. 
Additionally, gene expression analysis showed that the expression of several longevity 
genes requires both HSF-1 and DAF-16. This evidence points to the possibility that both 
transcription factors function together downstream of daf-2 (insulin/IGF-like receptor) to 
promote longevity. Our data showed that the reduction of insulin/IGF-like signaling leads 
                                                 
* The data from this chapter has been published in: Chiang et. al., HSF-1 regulators DDL-1/2 link 




to an increase in HSF-1 oligomerization, post-translational modification, nuclear 
accumulation, and HSF-1 dependent gene expression, suggesting that HSF is directly 
regulated by insulin/IGF-like signaling.  
 
In this study, we demonstrated that two novel genes, ddl-1 and ddl-2, influence lifespan 
and thermotolerance in C. elegans in an hsf-1 dependent manner. DDL-1 and DDL-2 
may negatively regulate HSF-1 activity by forming a protein complex with HSF-1. Our 
data suggested that insulin/IGF-like signaling may regulate HSF-1 through modulating 
the formation of this DDL-1 containing HSF-1 inhibitory complex (DHIC). Together, 




HSF-1 is a key factor that regulates aging in C. elegans. Previous studies have shown 
that HSF-1 and its downstream targets, including a group of small heat-shock proteins, 
may act in concert in insulin/IGF-like signaling to regulate longevity in C. elegans. Similar 
to daf-16, it has been shown that hsf-1 is required for daf-2 mutation to extend lifespan, 
as the lifespan extension by daf-2 inactivation is abolished by hsf-1 mutation [2]. 
Moreover, it has been shown that the expression of a subset of heat-shock protein is 
increased in daf-2 mutants and is partially required for DAF-2-mediated longevity 
phenotypes [2]. These observations imply that the insulin/IGF-like signaling pathway 





The activation of HSF-1 is a multi-step process in C. elegans 
In C. elegans, HSF-1 is a key transcription factor that regulates cellular responses to 
various proteotoxic stresses. Previous studies in mammals demonstrated that HSF1 is 
constitutively present in cells and is activated upon the encounter of proteotoxic stresses. 
It has been demonstrated in many systems that the activation of HSF1 is tightly 
controlled. The regulation of HSF appears to be a multi-step process involving 
oligomerization, post-translational modification, nuclear translocation, acquisition of DNA 
binding activity and transcriptional activity [95,96]. The multi-step activation of HSF is 
very well studied in mammals. However, in C. elegans, whether the activation of HSF-1 
shares common mechanisms with its mammalian homologs is not known; moreover, the 
activation of C. elegans HSF-1 has not been studied in detail. Recent results from our lab 
done by Dr. Tsui-Ting Ching and Dr. Hee Chul Lee have demonstrated that C .elegans 
HSF-1 responds to heat stress, and the activation of HSF-1 is also a multi-step process. 
 
As observed in other systems, we found that oligomerization of HSF-1 occurs upon 
heat-shock in C. elegans. Our analysis also indicates that post-translational modification 
(PTM) of HSF-1 occurs after heat-shock in a time-dependent manner. This change in 
PTM may represent a shift from either a non-modified to a modified form of HSF-1, or a 
shift between two different post-translationally modified forms of HSF-1 in response to 
heat-shock. Further analysis revealed that phosphorylation(s) may be responsible for the 
majority of the PTM observed in HSF-1. In humans, there are currently 31 identified 
Ser/Thr phosphorylation sites on HSF1 [97]. These phosphorylation sites are constitutive 




Acquiring DNA binding activity to the heat-shock element (HSE), a pentanucleotide DNA 
motif (5’-nGAAn-3‘) located in the upstream regulatory region of HSF target genes, is 
required for HSF to become transcriptionally active. By using electrophoretic mobility 
shift assay (EMSA) developed in our lab for worm HSF-1, we found that there is an 
increased level of HSF-1 that forms a protein complex with biotin-labeled HSE probes 
upon heat stress, indicating that heat-shock leads to an increase in HSF-1 DNA binding 
activity. 
 
We created a transgenic line that expresses HSF-1::GFP under the control of its own 
promoter and examined its expression pattern. HSF-1::GFP is expressed in intestinal 
cells, body wall muscle cells, and hypodermal cells, as well as many head and tail 
neurons. Under unstressed conditions, HSF-1::GFP is localized to a similar extent in the 
nucleus and cytoplasm. After heat stress, HSF-1::GFP accumulates in the nuclei of 
intestinal cells. To examine further whether HSF-1::GFP is biologically functional, we 
created a transgenic line with the same HSF-1::GFP expressing construct in hsf-1(sy441) 
mutant, an hsf-1 loss-of-function mutant known to display shortened lifespan, egg-laying 
defects, and larval arrest at elevated temperature [98]. We found that the overexpression 
of HSF-1::GFP rescued the longevity defect resulting from hsf-1(sy441) mutations as 
well as produced a significant lifespan extension in a wild-type background, suggesting 
that the GFP::HSF-1 is biologically functional. Together, our findings suggested that, 
similar to the activation of HSF in other systems, the activation of HSF-1 in C. elegans is 





DDL-1 and DDL-2 as potential HSF-1 regulators 
ddl-1 and ddl-2 (ddl, daf-16 dependent longevity) were previously identified from a 
genome-wide RNAi library screen for longevity genes. Inactivation of ddl-1 and ddl-2 by 
RNAi were found to extend lifespan by 20-30%, suggesting potential roles for ddl-1 and 
ddl-2 in longevity regulation. Moreover, previous yeast-two hybrid data suggested that 
DDL-1 may physically interact with DDL-2 and heat-shock factor binding protein-1 
(HSB-1), a HSF-1 negative regulator known to attenuate HSF-1 activity through an 
inhibitory binding with HSF-1. This evidence indicates a possibility that DDL-1 and 
DDL-2 regulate longevity through modulating HSF-1 activity. Interestingly, the predicted 
human ortholog of DDL-1, CCDC53 (coiled-coil containing protein 53) and HSB-1 human 
ortholog, HSBP-1, were found to interact with each other by yeast-two hybrid [99], 
implying that the biological function of DDL-1 and DDL-2 may be evolutionally 
conserved.  
 
2-3 Material and Methods 
C. elegans Strains 
The following alleles and strains were used in the study:  
CH116: hsb-1(cg116)IV,  
PS3551: hsf-1(sy441)I,  
VC2193: ddl-1(ok2916)II,  
RB2380: ddl-2(ok3235)II,  
EQ14: iqEx5[pAH47(ddl-1p::gfp) + pRF4(rol-6)],  
EQ64: iqEx25[pAH47(ddl-1p::ddl-1::gfp) + pRF4(rol-6)], 
EQ73: iqIs28[pAH71(hsf-1p::hsf-1::gfp) + pRF4(rol-6)],  
 
 24
EQ84: hsf-1(sy441)I; iqEx34[pAH71(hsf-1p::hsf-1::gfp) + pAH100(myo-3::rfp)],  
EQ104: iqEx39[pAH24(ddl-2p::gfp) + pRF4(rol-6)], 
EQ106: iqEx40[pAH79(ddl-2p::FLAG-ddl-2) + pRF4(rol-6)], 
EQ135: iqIs45[pAH87(ddl-1p::FLAG-ddl-1) + pAH76(hsf-1p::myc-hsf-1) + pRF4(rol-6)], 
EQ136: iqIs44[pAH75(ddl-1p::HA-ddl-1) + pRF4(rol-6)],  
EQ140: iqIs37[pAH76(hsf-1p::myc-hsf-1) + pRF4(rol-6)],  
EQ146: ddl-1(ok2916)II; out-crossed 6x to Hsu lab N2,  
EQ149: ddl-2(ok3235)II; out-crossed 6x to Hsu lab N2,  
EQ150: hsb-1(cg116)IV; CH116 out-crossed 4x to Hsu lab N2, 
EQ155: iqIs43[pAH75(ddl-1p::HA-ddl-1) + pAH79(ddl-2p::FALG-ddl-2) + pRF4(rol-6)], 
EQ160: ddl-1(ok2916)II; hsb-1(cg116)IV,  
EQ161: ddl-2(ok3235)II; hsb-1(cg116)IV,  
EQ163: ddl-1(ok2916)II; ddl-2(ok3235)II,  
EQ187: ddl-1(ok2916)II; iqIs44[pAH75(ddl-1p::HA-ddl-1) + pRF4(rol-6)], 
EQ193: hsb-1(cg116)IV; iqIs44[pAH75(ddl-1p::HA-ddl-1) + pRF4(rol-6)]. 
PS3551, CH116, VC2193, RB2380 and wild-type Caenorhabditis elegans (N2) strains 
were obtained from the Caenorhabditis Genetic Center. 
 
For the generation of transgenic animals, a plasmid DNA mix was microinjected into the 
gonad of young adult hermaphrodite animals, using the standard method. F1 progeny 
were selected on the basis of the roller phenotype or GFP expression. Individual F2 
progenies were isolated to establish independent lines. Wild-type (N2) animals were 
microinjected to generate these strains. For the generation of the EQ14 strain, the 
plasmid DNA mix consisted of 30 ng/µl pAH13 and 80 ng/µl pRF4. For the generation of 
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the EQ64 strain, the plasmid DNA mix consisted of 15 ng/µl pAH47 and 80 ng/µl pRF4. 
For the generation of the EQ70 strain, the plasmid DNA mix consisted of 30 ng/µl pAH71 
and 80 ng/µl pRF4. For the generation of the EQ104 strain, 100 ng/µl pAH24 plasmid 
DNA was used. For the generation of the EQ106 strain, the plasmid DNA mix consisted 
of 15 ng/µl pAH79 and 80 ng/µl pRF4. For the generation of the EQ135 strain, the 
plasmid DNA mix consisted of 15 ng/µl pAH87, 15 ng/µl pAH76, and 80 ng/µl pRF4. For 
the generation of the EQ136 strain, the plasmid DNA mix consisted of 5 ng/µl pAH44 and 
100 ng/µl pRF4. For the generation of the EQ140 strain, the plasmid DNA mix consisted 
of 15 ng/µl pAH76 and 15 ng/µl pRF4. For the generation of the EQ155 strain, the 
plasmid DNA mix consisted of 15 ng/µl pAH75, 15 ng/µl pAH79, and 80 ng/µl pRF4. 
Microinjecting N2 animals with 100ng/µl pRF4 (rol-6) alone did not affect the mean 
lifespan of N2 animals grown on either OP50, HT115, or RNAi bacteria that were 
examined in this study. 
 
RNA-interference (RNAi) Experiments 
The identity of all RNA interference (RNAi) clones was verified by sequencing the inserts 
using M13-forward primer. All clones were isolated from Julie Ahringer's RNAi library. 
HT115 bacteria transformed with RNAi vectors expressing dsRNA of the genes of 
interest were grown at 37°C in LB with 10 μg/ml tetracycline and 50 μg/ml carbenicillin, 
then seeded onto NG-carbenicillin plates and supplemented with 100 μl 0.1M IPTG. The 
bacterial strain containing empty vector L4440 was used as the control. 
 
Lifespan Analysis 
Lifespan analysis was conducted at 20°C as previously described unless otherwise 
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stated [100]. RNAi treatments were carried out by adding synchronized eggs to plates 
seeded with the RNAi bacteria. Worms were moved to plates with fresh RNAi bacteria 
every 2 days until reproduction ceased. Worms were then moved to new plates every 
5-7 days for the rest of the lifespan analysis. Viability of the worms was scored every 2–3 
days. 
 
Preparation of Worm Nuclear Extracts 
Frozen worm pellets were homogenized in a Kontes Pellet Pestle® tissue grinder in the 
presence of an equal volume of 2X NPB buffer (20 mM HEPES, pH 7.6, 20 mM KCl, 
3 mM MgCl2, 2 mM EDTA, 0.5 M sucrose, 1 mM dithiothreitol, protease inhibitors, 
phosphatase inhibitors). Cells were pelleted (4000 g, 5min, 4°C) and then homogenized 
20 strokes with pestle A of the Dounce homogenizer. The suspension was then washed 
three times in NPB buffer containing 0.25% NP-40 and 0.1% Triton X-100. The nuclei 
were pelleted again and extracted with 4x volume of HEG buffer (20 mM HEPES, pH 7.9, 
0.5 mM EDTA, 10% glycerol, 0.42 M NaCl, 1.5 mM MgCl2, and protease inhibitors) at 
4°C for 45 min. The nuclear fraction was collected by centrifugation at 14,000 g, 4°C for 
15 min. Protein concentrations were determined by Bradford assay. 
 
Electrophoretic Mobility Shift Assay 
1 μg of worm nuclear extracts (NE) was incubated with 1 μg/μl Poly (dI⋅dC) and 1 nM 
biotin-labeled oligonucleotide containing the HSE sequence for 15 min at room 
temperature in binding buffer [20 mM HEPES, pH 7.6, 5 mM EDTA, 1 mM dithiothreitol, 
150 mM KCl, 50 mM (NH4)2SO4, 1% Tween 20 (v/v)]. The biotin-labeled oligonucleotides 
were synthesized based on the sequence covering the HSE in the promoter region of 
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hsp-16.1 (detail sequence listed below). Following native 3.5% polyacrylamide gel 
electrophoresis, HSF-1-HSE DNA complexes were visualized by LightShift 







Worms were sonicated on ice for a total of 1 min followed by thawing frozen worm pellets 
in HEG buffer (20 mM HEPES, pH 7.9, 0.5 mM EDTA, 10% glycerol containing 0.42 M 
NaCl, 1.5 mM MgCl2, and protease inhibitors). Worms were then dispersed by repeated 
pipetting followed by incubation on ice for 15 min. The samples were centrifuged at 
14,000 rpm for 15 min and the supernatants were collected. Whole worm extracts were 
then incubated with 1 mM EGS [ethylene glycol bis(succinimidyl succinate)]. EGS was 
added at a final concentration of 1 mM and incubated at room temperature for 30 min. 
After quenching the cross-linking reactions with excess 1 M Tris-Cl, pH 8.5, samples 
were resolved by 6% SDS-polyacrylamide gel electrophoresis and analyzed by western 
blot with anti-HSF1 antibody. 
 
RNA Isolation and Quantitative RT-PCR 
Total RNA was isolated from approximately 3,000 worms, and cDNA was made from 4 
μg of RNA using Superscript III RT (Invitrogen). TaqMan real-time qPCR experiments 
were performed for each gene using the Chromo 4 system (MJ Research). Relative 
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mRNA levels of the genes of interest were calculated and normalized against the internal 
control (act-1, the β-actin) and compared to the stated control (= 1). 
 
Stress Assay 
For thermotolerance assays, eggs from N2 worms were transferred to plates seeded 
with either vector only control, ddl-1 RNAi, or ddl-2 RNAi bacteria and grown to Day 1 
adulthood. Worms were then transferred to plates without any food and heat-shocked at 
35°C. Viability of the worms was scored every 2-3 hr. For oxidative stress assays, eggs 
from N2 worms were transferred to plates seeded with vector only control, ddl-1 RNAi, 
or ddl-2 RNAi bacteria. The worms were transferred every day to separate them from 
their progenies until Day 5 of adulthood. Worms were then transferred to 24-well plates 
and soaked in 300 mM of paraquat. Worms were checked every two hours for their 
viability. 
 
HSF-1 Nuclear Localization Assay 
Day 2 adult animals carrying an integrated hsf-1::gfp array (EQ73) grown on a vector 
control (VC) or different RNAi bacteria were either unstressed or heat shocked on 37°C 
heat block for 30 min. Fluorescence images of the animals were then taken and scored 
blindly for the nuclear accumulation of HSF-1::GFP protein in the intestinal cells (white 
arrows). At least 100 animals were scored per RNAi treatment per experiment. Worms 
were classified into separate groups according to the nuclear/cytosolic (n/c) ratio of GFP 
intensity in the intestinal cells. 
 
Coimmunoprecipitation in 293T Cells 
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Twenty-four hours after 293T cells were transfected with various combinations of 
different plasmids containing HA-ddl-1, FLAG-ddl-1, FLAG-ddl-2, myc-hsb-1, or 
myc-hsf-1 cDNA cells were washed with PBS and resuspended in L-RIPA buffer [50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EGTA, 0.1% Triton X-100 supplemented with 
Protease Inhibitor Cocktail Complete Mini (Roche) and 1 mM sodium orthovanadate]. 
The cell suspensions were then placed on ice for 10 min before being subjected to 
centrifugation at 14,000 × g for 10 min at 4°C. The supernatants were then collected. 
The protein levels of whole-cell extract (WCE) were quantified by Bradford assay. For 
each sample, 1,000 μg of total protein was used for the IP experiments. Anti-HA 
(Convance, #MMS101P), anti-FLAG (Sigma, #F3165), or anti-Myc (Cell Signaling, 
#2276) antibodies were added to WCE at 1:150, 1:300, and 1:500 dilutions, respectively. 
Five mg of anti-mouse rabbit polyclonal antibody was then added as a bridge antibody. 
Reactions were incubated at 4°C with gentle shaking overnight. 30 μl of 50% Protein A 
agarose beads (Sigma #P7786; preblocked by 10% BSA) were added into the solutions 
4–5 hr after the initiation of the incubation. The beads were washed three times with 
L-RIPA buffer supplemented with 50 μg/ml ABESF and 1 mM sodium orthovanadate 
before being subjected to western blot analysis. 
 
Coimmunoprecipitation in Worms 
About 15,000 synchronized day 1 adult worms grown on either control or RNAi bacteria 
at 20°C were harvested by washing three times with cold M9 buffer and one more time 
with HB-high salt buffer (10 mM HEPES, pH 7.9; 10 mM KCl; 1.5 mM MgCl2; 0.1 mM 
EDTA; 0.5 mM EGTA; 44 mM Sucrose; 100 mM NaCl; 0.5% Triton X-100). Worm pellets 
were then resuspended in 3× volume of HB-high salt buffer supplemented with Protease 
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Inhibitor Cocktail Complete Mini (Roche), 2.5 mM sodium pyrophosphate, 20 mM 
β-glycerolphosphate, and 1 mM sodium orthovanadate. The pellets were immediately 
frozen and stored in liquid nitrogen for future use. Frozen suspensions were thawed, 
homogenized with a Dounce homogenizer (30 strokes with a pestle B), and centrifuged 
at 14,000 × g at 4°C for 20 min. Supernatants were collected and total protein 
concentrations were quantified by Bradford assay. If necessary, crosslinking was done 
by incubating worm protein extracts with 1 mM EGS (ethylene glycol bis[succinimidyl 
succinate]) at 25°C for 30 min. The crosslinking reactions were stopped by adding and 
incubating with 20 mM Tris-HCl (pH 7.4) for an additional 30 min. For 
immunoprecipitation, 30 μl of anti-HA agarose beads (Sigma #A2095) were added to 
1,500 mg of protein extract and incubated with gentle shaking at 4°C overnight. The 
beads were then washed three times with HB-high salt buffer supplemented with 50 
μg/ml ABESF and 1 mM sodium orthovanadate before being subjected to western blot 
analysis. 
 
Western Blot Analysis 
The samples were subjected to SDS-PAGE and transferred to a PVDF membrane 
(Millipore). The transblotted membrane was washed three times with TBS containing 
0.05% Tween 20 (TBST). After blocking with TBST containing 5% nonfat milk for 60 min, 
the membrane was incubated with the primary antibody indicated (e.g., anti-HSF1, 
Calbiochem, #385580) at 4°C for 12 hr and washed three times with TBST. The 
membrane was then probed with HRP-conjugated secondary antibody for 1 hr at room 
temperature and washed with TBST three times. Finally, the immunoblots were detected 




2-4-1 DAF-2 insulin/IGF-like signaling inhibits HSF-1 activity 
As previously suggested, HSF-1 may play an important role in the insulin/IGF-like 
signaling pathway [2,68]. Assuming that the insulin/IGF-like signaling pathway directly 
modulates HSF-1 activity, we postulated that the inactivation of DAF-2 would affect the 
multi-step activation of HSF-1, including nuclear translocation, post-translational 
modification, DNA binding activity, and downstream gene expression. We first 
investigated whether the reduction of insulin/IGF-like signaling activity affects HSF-1 
nuclear translocation. Our data showed that a reduction of DAF-2 activity caused a 
significant increase in the level of nuclear HSF-1 under unstressed or heat-shock 
conditions (Figure 10A). Inactivation of akt-1, another component of the insulin/IGF-like 
signaling, also led to an increase in HSF-1 nuclear translocation (Figure 10A). 
DAF-2-mediated HSF-1 nuclear translocation seemed to be daf-16 independent, as 
knockdown of daf-16 did not impact daf-2-mediated HSF-1 nuclear translocation (Figure 
10A). 
 
We have also found that the reduction of DAF-2 activity affects HSF-1 DNA binding 
activity. As compared to wild-type N2 animals, daf-2 deficient animals exhibited 
substantially increased HSF-1 DNA binding activity under both unstressed and 
heat-shocked conditions, suggesting that the activity of HSF-1 is higher in daf-2 
RNAi-treated animals (Figure 10B and C). An elevated HSF-1 activity may allow a more 
robust response against heat-shock and would thereby promote stress resistance and 
longevity in daf-2 animals. Nuclear accumulation of oligomerized and post-translationally 
modified HSF-1 (active form of HSF-1) leads to an increase in HSF-1 DNA binding 
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activity. Indeed, the western blot analysis showed that the level of post-translationally 
modified HSF-1 is increased in daf-2 RNAi-treated animals under both stressed and 
non-stressed conditions (Figure 10D and E), suggesting an increased level of active 
HSF-1 upon DAF-2 inactivation. Interestingly, we have also observed that the amount of 
total HSF-1 is increased in response to heat stress or daf-2 knockdown, whereas the 
level of unmodified HSF-1 remained largely unaltered (Figure 10E). However, this 
increase in the amount of HSF-1 protein is unlikely to be a result of a change in hsf-1 
mRNA expression, as hsf-1 mRNA levels did not appear to be increased in daf-2 
RNAi animals compared to control animals (Figure 11A). It is possible that 
post-transcriptionally modified and DNA-bound HSF-1 proteins may be less prone to 
degradation. 
 
Finally, to examine whether increased HSF-1 DNA binding activity leads to an increase in 
HSF-1 transcriptional activity, we measured the expression of known HSF-1 downstream 
target genes, including two small hsps (i.e. hsp-16.2 and sip-1) and two hsp-70s (i.e. 
F44E5.5 and C12C8.1), by quantitative RT-PCR. Indeed, we found that the expression 
levels of these target genes were increased in daf-2 RNAi-treated animals under both 
stressed and unstressed conditions (Figure 11B-E). Taken together, these results 
indicated that HSF-1 activity, including its multi-step activation process, is subject to 
negative regulation by the insulin/IGF-like signaling pathway.  
 
Overall, our findings strongly suggested that HSF-1 activity is regulated by the DAF-2 
pathway. To further understand how HSF-1 is controlled by insulin/IGF-like signaling, we 
next attempted to elucidate the mechanism underlying this regulation. In the following 
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sections, I will focus on ddl-1 and ddl-2, two novel daf-16-dependent longevity (ddl) 
genes, and their potential role in HSF-1 regulation in the context of insulin/IGF-like 
signaling.  
 
2-4-2 ddl-1, ddl-2 and hsb-1 negatively regulate stress resistance and longevity 
Since DDL-1 and DDL-2 were previously suggested to play a role in longevity [101], we 
first tested whether these two genes also play a role in stress resistance. We found that 
ddl-1 and ddl-2 RNAi animals are more resistant to both heat and oxidative stress, 
indicating that DDL-1 and DDL-2 may modulate stress response (Figure 12A and B). 
Moreover, since previous study showed that the depletion of ddl-1 and ddl-2 by RNAi 
extends lifespan in C. elegans [101], we also attempted to verify this observation with 
deletion mutants. The lifespans of ddl-1 and ddl-2 deletion and overexpressing animals 
were tested. Our results showed that animals with ddl-1(ok2916) and ddl-2(ok3235) 
deletion alleles displayed significantly extended lifespans, by about 20-30% (Figure 12C). 
In addition, DDL-1 and DDL-2 have been suggested to interact with HSB-1, a known 
HSF-1 inhibitor; we thus examined the longevity phenotype of hsb-1 deletion mutants. 
Similarly, hsb-1(cg116) null mutants are long-lived (about 50% increased longevity), 
consistent with the phenotype of ddl-1 and ddl-2 animals (Figure 12C). Together, these 
results may indicate that DDL-1, DDL-2 and HSB-1 have similar biological function. 
 
Interestingly, overexpression of DDL-1 and/or DDL-2 in wild-type background was not 
sufficient to alter lifespan (Figure 12D and E). However, we did observe that the 
overexpression of DDL-1 reversed the long-lived phenotype of ddl-1(ok2916) mutant 
animals, suggesting that the DDL-1 transgene is functional (Figure 12F). It is possible 
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that the amount of DDL-1 and DDL-2 is not the limiting factor for longevity regulation. 
DDL-1 and DDL-2 may have to collaborate with other proteins to modulate longevity and 
stress resistance; thus the overexpression of one protein may not be sufficient to 
produce significant longevity phenotype. 
 
2-4-3 ddl-1 and ddl-2 are negative regulators of HSF-1 
To determine the potential role of DDL-1 and DDL-2 as negative regulators of HSF-1, we 
examined whether ddl-1 and ddl-2 inactivation affect HSF-1 activation. In collaboration 
with Dr. Hee Chul Lee and Tsui-Ting Ching in our lab, we examined the effect of 
ddl-1 or ddl-2 inactivation on HSF-1 transcriptional activity by quantitative RT-PCR. 
Inhibition of ddl-1 or ddl-2 led to increases in mRNA transcription of all four HSF-1 
targets, hsp-16.2, hsp-70s and sip-1 upon heat shock (Figure 13). However, under 
unstressed conditions, inhibition of ddl-1 or ddl-2 did not significantly elevate the mRNA 
level of hsf-1 targets, except for hsp-16.2 and sip-1 in ddl-1 RNAi animals. We found that 
there was a significantly higher level of nuclear localized HSF-1 in ddl-1 RNAi animals 
under both stressed and unstressed conditions and in ddl-2 RNAi animals under 
stressed conditions (Figure 14). Inhibition of ddl-1 appeared to increase DNA binding 
activity of HSF-1 both before and after heat shock (Figure 14B and C). There was also a 
significant increase in DNA binding activity of HSF-1 in ddl-2 RNAi animals under 
stressed conditions, whereas inhibiting ddl-2 under unstressed conditions produced no 
significant effect (Figure 14B and C). We also found an increased level of 
post-translationally modified HSF-1 in ddl-1 RNAi animals under stressed and 
unstressed conditions (Figure 14D and E). Curiously, the level of HSF-1 PTM was 
slightly reduced in ddl-2 RNAi animals, suggesting that DDL-1 and DDL-2 may regulate 
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HSF-1 activity via both overlapping and distinct mechanisms. Together, these findings 
strongly suggested that HSB-1, DDL-1, and DDL-2 function as negative regulators of 
HSF-1 in C. elegans. 
 
2-4-4 hsf-1 is required for ddl-1, ddl-2 and hsb-1 to promote longevity 
We hypothesized that DDL-1, DDL-2 and HSB-1 regulate HSF-1 activity through the 
formation of an inhibitory complex. To test this model, we first asked whether hsf-1 is 
required for ddl-1, ddl-2 and hsb-1-mediated longevity. We utilized hsf-1 mutant animals 
carrying hsf-1(sy441), an hsf-1 loss-of-function allele. The hsf-1(sy441) animals 
displayed decreased lifespans, egg-laying defects, and larval arrest at elevated 
temperatures [98]. This allele completely abolished lifespan extension by ddl-1 and ddl-2 
RNAi, showing that hsf-1 is required for ddl-1 and ddl-2 inactivation to extend lifespan 
(Figure 17A and B). Similarly, the inactivation of hsf-1 by RNAi abolished lifespan 
extension by hsb-1(cg116) deletion (Figure 17C). Our genetic epistasis analysis clearly 
showed the requirement of hsf-1 for ddl-1, ddl-2 and hsb-1 mutation to extend lifespan, in 
agreement with our model that DDL-1, DDL-2 and HSB-1 regulate HSF-1 to influence 
longevity.  
 
2-4-5 ddl-1, ddl-2 and hsb-1 might function in the same pathway 
A previous yeast-two hybrid interactome study in C. elegans suggested that DDL-1 may 
interact with HSB-1 and DDL-2 [99], implying that they may function in the same 
molecular pathway. To test whether these genes share a common mechanism to 
influence HSF-1 activity, we created combinations of ddl-1, ddl-2 or hsb-1 compound 
mutants and measured their lifespan. Either ddl-1(ok2916) or ddl-2(ok3235) mutations 
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did not lead to further extensions of lifespan in long-lived hsb-1(cg116) (Figure 17E and 
F). We also found that ddl-1(ok2916); ddl-2(ok3235) double mutant animals did not live 
longer than ddl-1(ok2916) or ddl-2(ok3235) single mutants (Figure 17D). Our RNAi 
experiments showed similar result, as ddl-1 and ddl-2 double RNAi did not lead to a 
longer lifespan extension than ddl-1 or ddl-2 RNAi alone (Table 1). Overall, these data 
indicated that the inactivation of ddl-1, ddl-2 and hsb-1 have no additive effect on 
longevity, strongly suggesting that these genes may genetically function in the same 
pathway and share a common mechanism to modulate HSF-1 activity. 
 
2-4-6 Physical interaction among HSF-1, HSB-1, DDL-1 and DDL-2 
We next attempted to elucidate how HSF-1 may be regulated by DDL-1 and DDL-2. 
Given that DDL-1 and DDL-2 are negative regulators of HSF-1 and may share a 
common mechanism with HSB-1 to modulate hsf-1-dependent longevity, we 
hypothesized that DDL-1, DDL-2 and HSB-1 may form an inhibitory complex that binds 
to HSF-1. To test our model, we first attempted to confirm previously reported 
DDL-1-HSB-1 and DDL-1-DDL-2 interaction by co-immunoprecipitation in cell culture. 
Epitope tagged HA-DDL-1 and FLAG-DDL-2 were co-expressed in 293T cells and 
immunoprecipitated by anti-HA antibody. We were able to detect FLAG-DDL-2, as we 
immunoprecipitated HA-DDL-1 (Figure 18A, left). Conversely, when we pulled down 
FLAG-DDL-2, we were able to detect HA-DDL-1 (Figure 18A, right). Similarly, to assess 
the interaction between DDL-1 and HSB-1, we co-expressed HA-DDL-1 and Myc-HSB-1 
and pulled down DDL-1 with anti-HA antibody. The result showed that Myc-HSB-1 can 
be co-immunoprecipitated with HA-DDL-1, and vice versa (Figure 18B). We were not 
able to detect the interaction between DDL-2 and HSB-1, even with the co-expression of 
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DDL-1.  DDL-2 and HSB-1 may not directly interact; thus, it is possible that the binding 
between DDL-1 & HSB-1 or DDL-1 & DDL-2 is obscured by our experimental conditions, 
including the duration of washing as well as the composition of our buffers. Nonetheless, 
our findings suggested that DDL-1 may physically interact with HSB-1 and DDL-2 and 
may be present in a protein complex containing all three of them. 
 
To ask whether the hypothesized inhibitory protein complex binds to HSF-1, we next 
tested whether HSF-1 is present in the same complex with DDL-1. Myc-HSF-1 and 
HA-DDL-1 were expressed in 293T cells and co-immunoprecipitated with anti-Myc or 
anti-HA antibodies. Indeed, we were able to detect the interaction between HA-DDL-1 
and Myc-HSF-1 (Figure 18C). In addition, the physical interaction between HSF-1 and 
HSB-1 has been previously suggested [84], further supporting our hypothesis that these 
HSF-1 negative regulators form a protein complex with HSF-1 to modulate its activity. 
 
To find out whether a similar protein complex is also present in C. elegans, we assessed 
the interaction between HSF-1 and DDL-1 by creating stable transgenic worms 
expressing HA-tagged DDL-1. Whole cell extracts from day 1 adult synchronized culture 
was prepared and immunoprecipitated by anti-HA antibody. We found that HSF-1 can be 
co-immunoprecipitated with HA-DDL-1 (Figure 18D). We also co-expressed HA-DDL-1 
and FLAG-DDL-2 in worms and successfully confirmed the interaction between DDL-1 
and DDL-2 (Figure 18E). Notably, the HSF-1-DDL-1 interaction appeared to be 
diminished in an hsb-1(cg116) null mutant background (Figure 18D, EQ193), indicating 
that the interaction between DDL-1 and HSF-1 largely depends on HSB-1. In other 




Overall, this biochemical evidence strongly suggested interactions between DDL-1 and 
its binding partners. However, we do not know exactly whether these interactions occur 
in vivo. We next investigated the interaction between DDL-1 and its binding partners in 
vivo by using bimolecular fluorescence complementation (BiFC) assay. With this system, 
we were able to visualize the formation of protein complexes in living animals. BiFC is a 
well-established method based on the complementation of two non-functional 
fluorescent protein fragments. These proteins can be fused to a pair of proteins of 
interest and expressed in vivo [102,103]. If the postulated interaction occurs, two 
fluorescent protein fragments will be brought into proximity, allowing the reformation of 
native fluorescent molecule and the emission of fluorescence. This approach not only 
enables the identification of protein-protein interactions, but also reveals the subcellular 
localization where the interaction occurs. We chose two fragments derived from YFP 
variant Venus, VN173 (1-173) and VC155 (155-238) as BiFC reporters. To examine the 
interaction between DDL-1 and HSB-1 in vivo, we created transgenic lines expressing 
both DDL-1::VN173 and HSB-1::VC155 driven by their own promoters (ddl-1 
promoter::ddl-1::VN173; hsb-1 promoter::hsb-1::VC155). We observed strong 
fluorescent signal in the cytosolic compartment of the intestine cells, indicating that 
DDL-1 and HSB-1 indeed physically interact in vivo (Figure 19). 
 
Taken together, based on these in vitro and in vivo analyses, we confirmed the 
previously reported protein-protein interaction and demonstrated the molecular 
interaction among HSF-1, HSB-1, DDL-1 and DDL-2. Overall, these findings support our 
hypothesis that these proteins form a complex called DDL-1 containing HSF-1 inhibitory 
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complex (DHIC) and that the formation of DHIC prevents HSF-1 oligomerization and 
subsequent activation. 
 
2-4-7 Tissue expression of ddl-1 and ddl-2 
Investigating the tissue expression of ddl-1 and ddl-2 will provide valuable insights into 
their site of action; therefore, we created transgenic animals carrying ddl-1 
promoter::ddl-1::gfp and ddl-2 promoter::ddl-2::gfp extrachromosomal arrays to 
determine DDL-1/2 tissue expression pattern as well as cellular localization. DDL-1::GFP 
is mainly expressed in the cytosolic compartment in the intestine as well as several 
neurons (Figure 15). The cytosolic localization of DDL-1 is in agreement with our BiFC 
result and our hypothesis that DDL-1, DDL-2 and HSB-1 form a complex that inhibits 
HSF-1 by cytosolic sequestration. However, we were unable to obtain stable ddl-2::gfp 
transgenic lines, presumably due to the instability of the fusion protein or the toxicity 
caused by overexpression. Instead, we generated animals carrying ddl-2 transcriptional 
fusion (ddl-2 promoter::gfp) that expresses GFP under ddl-2 promoter. Interestingly, 
unlike DDL-1, DDL-2 is largely expressed in a certain group of neurons in the head 
(particularily around the nerve ring) and tail (Figure 16). Further characterization 
revealed that DDL-2 is expressed not only in a subset of neurons, but also in some 
structure cells (hypodermal and ganglia cells), body wall muscle and a small number of 
adult intestinal cells. We do not know whether the expression of ddl-2 in these neurons is 




2-4-8 DDL-1 threonine phosphorylation is negatively regulated by insulin/IGF-like 
signaling 
As we overexpressed DDL-1 in mammalian cells, western blot analysis showed two 
bands at the expected size of DDL-1, suggesting possible post-translational 
modifications (PTMs) on DDL-1 (Figure 20A and B). Since phosphorylation is the most 
common type of PTM, we first tested whether phosphorylation is responsible for the 
observed mobility shift on DDL-1. Upon incubation with CIP (calf intestine alkaline 
phosphatase), the top band completely disappeared (Figure 20A), suggesting that 
DDL-1 is phosphorylated. Subsequent western blot analysis with anti-phospho-threonine 
antibody revealed that the modification(s) includes phosphorylation on at least one 
threonine residue (Figure 20B, left lane). 
 
We next attempted to examine whether DDL-1 phospho-threonine modification is also 
present in worms. Whole cell extracts of HA-DDL-1 expressing transgenic animals were 
prepared, immunprecipitated by anti-phospho-threonine antibody, and western blotted by 
anti-HA antibody. We were able to detect threonine phosphorylation on DDL-1 (Figure 
20C). Moreover, our result showed that inactivation of DAF-2 (insulin/IGF-like receptor) 
by RNAi leads to a significant increase of DDL-1 threonine phosphorylation (Figure 20C), 
indicating that DDL-1 phosphorylation status is subject to regulation by the 
insulin/IGF-like signaling. 
 
2-4-9 The insulin/IGF signaling pathway modulates formation of the DHIC 
complex 
Since protein phosphorylation represents a common mechanism for cellular signaling 
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and is known to exert its effect by the modulation of protein-protein interaction, our 
findings pointed to a possibility that the interaction between DDL-1 and its binding 
partners may be subject to regulation by the insulin/IGF-like signaling cascade. To test 
this hypothesis, we prepared synchronized cultures of HA-ddl-1 transgenic worms grown 
on control or daf-2 RNAi bacteria, and harvested at day 1 during the adulthood. Whole 
cell extracts were prepared, immunoprecipitated by anti-HA antibody, and analyzed by 
HSF-1 western blot. Our data showed that inactivation of daf-2 by RNAi disrupted the 
binding between HSF-1 and DDL-1 (Figure 20D and Figure 21A). Similarly, we observed 
that akt-1 inactivation led to a modest decrease in HSF-1-DDL-1 binding. These data 
strongly indicated that the activity of insulin/IGF signaling might affect the formation of 
the DHIC complex. In addition, we also observed that the interaction between HSF-1 and 
DDL-1 is not affected by heat stress, implying that the formation of DHIC may be 
heat-insensitive (Figure 21B). 
 
2-4-10 DDL-1 phosphorylation status may be important for DHIC complex 
formation 
As we demonstrated, the insulin/IGF-like signaling modulates DHIC complex formation 
and the level of DDL-1 threonine phosphorylation. To ask whether DDL-1 
phosphorylation plays a role in modulation of DHIC complex formation, we next used 
in-silico tools to predict phosphorylation on DDL-1. With ScanSite 
(http://scansite.mit.edu/) and PredPhospho (http://pred.ngri.re.kr/PredPhospho.htm), we 
were able to find five putative serine/threonine phosphorylation sites (T24, T84, T108, 




Given that DDL-1 is threonine phosphorylated in both mammalian cells and worms, it is 
likely that DDL-1 phosphorylation is a common mechanism shared by both organisms. 
Thus, we looked for conserved motifs present in worms (DDL-1) and mammals 
(CCDC53), and focused on putative phosphorylation sites located within these motifs. 
Sequence analysis showed high homology at the C-terminal of DDL-1 and CCDC53, a 
mammalian DDL-1 ortholog. In close proximity to this evolutionally conserved region, two 
residues on DDL-1, S181 and T182 are predicted to be phosphorylated by GSK3/CK1 
kinase family. Notably, CCDC53 T181, the homologous site for DDL-1 T182, was also a 
predicted phospho-threonine site. 
 
To verify the prediction result, we utilized serine/threonine dephosphorylation mimetic 
mutant. DDL-1 mutants that carry threonine-to-alanine mutation on putative 
phosphorylation sites were created by site-directed mutagenesis and expressed in 
mammalian cells. Western blot analysis showed that T182A (threonine-to-alanine) 
mutation completely eliminated threonine phosphorylation on DDL-1, indicating that 
T182 might be the only threonine phosphorylation site on DDL-1 (Figure 20B). Moreover, 
our western blot analysis showed that wild-type DDL-1 consistently appears as two 
bands, while T182A mutation partially eliminated the top band, suggesting that T182 
might not be the only PTM on DDL-1 (Figure 20B, top).  
 
Our attempt to examine S181, another putative phosphorylation site located in proximity 
to the conserved motif, was not successful. We were unable to confirm the 
phosphorylation status of S181, since the level of serine phosphorylation is not 
detectable with anti-phospho-serine antibody. It is known that the specificity and affinity 
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of pan-phospho-antibody depends on the sequence context. Thus, whether S181 is 
phosphorylated remains uncertain. However, our analysis showed that S181A/T182A 
double mutation completely eliminates the DDL-1 top band, suggesting that the 
phosphorylation on S181 remains possible (data not shown).  
 
As we demonstrated, T182 is the only confirmed phosphorylated residue located in 
conserved motifs of DDL-1. To examine the potential role of T182 in HSF-1 regulation, 
we tested whether the T182 phosphorylation is crucial for the formation of DHIC. To this 
end, we created T182A (threonine-to-alanine) mutant to evaluate the impact of 
dephosphorylation on the interaction between DDL-1 and its binding partners. Wild-type 
and mutant HA-tagged DDL-1 were expressed in 293T cells and co-immunoprecipitated 
by anti-HA antibody. We found that T182A mutation enhanced the interaction between 
HSF-1 and DDL-1 (Figure 20E). This result suggested that dephosphorylated DDL-1 
may favor the formation of DHIC, and consequently inhibit HSF-1 oligomerization and 
subsequent activation. This finding may indicate that the phosphorylation of DDL-1 is 
likely to play a role in modulating the formation of DHIC. We did not formally evaluate 
whether T182 phosphorylation impacts the interaction among all DHIC components. 
However, we did observe that T182A mutation does not affect the binding between 
DDL-1 and DDL-2, suggesting that at least T182 phosphorylation status does not play a 
role in modulating DDL-1-DDL-2 interaction (Figure 20F).  
 
Since T182 may be important for the insulin/IGF-like signaling to regulate HSF-1 activity, 
we next attempted to determine whether T182 also play a role in DAF-2 longevity. We 
created transgenic rescue animals expressing wild-type or T182A DDL-1 mutant in a 
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ddl-1(ok2916) background, treated with daf-2 RNAi bacteria and measured their lifespan. 
Presumably, if T182A is important for DAF-2 longevity, the expression of DDL-1 T182A in 
ddl-1 mutants should lead to a stronger suppression of DAF-2 longevity than the 
expression of wild-type DDL-1 in the same background. We did not observe strong 
suppression of DAF-2 longevity by T182A rescue mutants (Figure 22). T182A rescued 
animals appeared to have slightly shorter lifespans than their wild-type counterparts; 
however, the difference was not statistically significant. It is possible that overexpressing 
mutant DDL-1 alone is not sufficient to affect DAF-2 longevity. The co-expression of 
other DHIC components (i.e. DDL-2 and HSB-1) may be necessary. Further, T182 on 
DDL-1 may only partially contribute to DAF-2-mediated HSF-1 regulation; thus, 
threonine-to-alanine mutation on T182 minimally impacted DAF-2 longevity. It is possible 
that the insulin/IGF-like signaling modulates DHIC formation through multiple parallel 
mechanisms. 
 
It is currently unclear which kinase(s) catalyzes the phosphorylation on T182 of DDL-1. 
In an attempt to identify DDL-1 kinase(s), we examined whether DDL-1 is the target of 
the glycogen synthase kinase 3 (GSK3) family, as T182 is predicted to be 
phosphorylated by a GSK-like kinase. In C .elegans, two GSK3-like kinases are present: 
gska-3 (GSK3α) and gsk-3 (GSK3β). We found that the inactivation of both GSKs did not 
alter the level of phospho-threonine on DDL-1 (Figure 23). Moreover, the knockdown of 
akt-1 did not lead to a decrease in DDL-1 phospho-threonine level; on the contrary, AKT 
inhibition promoted DDL-1 threonine phosphorylation. These data clearly showed that 
neither GSKs nor AKT phosphorylates DDL-1. Further investigations are required to 





2-5-1 The insulin/IGF-like signaling modulates HSF-1 activity 
Although the roles of HSF-1 and heat-shock responsive genes in regulating stress 
response and longevity have been previously described in C. elegans, the molecular 
mechanism by which HSF-1 activity is modulated in response to different environmental 
or hormonal cues remains largely unclear. Our work presented here provides evidence 
for a mechanism underlying the regulation of HSF-1 activation by the insulin/IGF-like 
signaling pathway, one of the major regulatory pathways for longevity. Our model 
suggested that DDL-1, DDL-2 and HSB-1 negatively regulate HSF-1 activity by forming a 
protein complex with HSF-1 and consequently reduces the amount of HSF-1 susceptible 
to heat stress-induced activation. We believe that the insulin/IGF-like signaling controls 
HSF-1 activity, at least in part, by regulating the formation of DDL-1-containing HSF-1 
inhibitory complex (DHIC), possibly by modulating threonine phosphorylation on DDL-1. 
 
2-5-2 Formation of DHIC 
It has been previously demonstrated that in mammals, HSF1 activity is tightly regulated 
by repressive interaction with multiple chaperone complexes containing proteins such as 
HSP40, HSP70 and HSP90 [96]. These proteins form an inhibitory complex with HSF1, 
thereby preventing oligomerization and subsequent activation of HSF1. Analogously, we 
found that DDL-1, DDL-2 and HSB-1, a previously reported HSF negative regulator, may 
regulate HSF-1 activity through the formation of an inhibitory complex with HSF-1.  
 
The previous yeast-two hybrid interactome data have provided preliminary evidence for 
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the interactions among DHIC components. Several lines of evidence in our study 
suggested that these protein interactions are likely to occur in vivo. First, our biochemical 
assay has confirmed the pair-wise interactions between DDL-1-DDL-2, DDL-1-HSB-1 
and DDL-1-HSF-1 in cell culture (Figure 18A-C). We have also showed that the 
interactions between DDL-1-HSF-1 and DDL-1-DDL-2 are present in C. elegans. 
Second, the protein-protein interaction between DDL-1 and HSF-1 can be disrupted by 
genetic manipulations, such as daf-2 RNAi knockdown, without affecting the overall 
protein levels of DDL-1 (Figure 20D). Third, our in vivo BiFC assay clearly showed that 
DDL-1 and HSB-1 interact in cytosolic compartment of the intestinal cells (Figure 19). 
Moreover, human orthologs of DDL-1, DDL-2, and HSB-1 (CCDC53, WASH2 and 
HSBP1, respectively) have been reported to either interact with each other or coexist in 
the same protein complex [104,105], suggesting that the formation of DHIC may be an 
evolutionally-conserved process. 
 
Although our BiFC assay clearly showed direct interaction in vivo between DDL-1 and 
HSB-1 (Figure 19), our attempt to examine the interaction between DDL-1 and HSF-1 
with BiFC was not successful, as HSF-1::VC155/DDL-1::VN173 produced a signal at 
level similar to its negative control. There are several possibilities. First, fluorescent 
fusion protein (HSF-1::VC155) may not fold properly to produce functional fluorophore. 
Second, VN173 or VC155 may sterically hinder the interaction between HSF-1 and 
DDL-1. Most importantly, the reconstitution of BiFC fluorophore usually occurs at a 
relatively short distance (~7nm) [106]. If the interaction between HSF-1 and DDL-1 is 
distant and indirect, fluorescence complementation will not occur efficiently and thus 
result in low signal. Indeed, our co-immunoprecipitation data showed that the absence of 
 
 47
HSB-1 greatly diminished the interaction between HSF-1 and DDL-1 (Figure 18D), 
indicating that DDL-1-HSF-1 interaction may be indirect and largely depend on the 
presence of HSB-1. Thus, an optimized design for BiFC assay will be necessary for 
studying the detail of DHIC formation in the future. 
 
The expression pattern of HSF-1, DDL-1 and HSB-1 suggested that these proteins may 
co-localize in the same cell types. HSF-1 is expressed in almost all cell types, as 
observed in our hsf-1::gfp transgenic lines; whereas DDL-1 is mainly expressed in 
pharynx, intestine, body wall muscle, and a subset of head and tail neurons (Figure 15). 
HSB-1 has been reported to be expressed in a variety of tissues such as pharynx, 
intestine, muscles, and tail neurons [107]. The overlapping expression pattern among 
HSF-1, HSB-1, and DDL-1 supports the idea that these proteins interact with each other 
in vivo. DDL-2, on the contrary, is mainly expressed in a subset of neurons, larval body 
wall muscles, and a small number of adult intestinal cells (Figure 16). However, it is not 
clear whether the expression of DDL-2 in those neurons is critical in regulating HSF-1 
activity and longevity. Further studies will be required to address these questions. 
 
2-5-3 Direct regulation of HSF-1 activity by insulin/IGF-like signaling through 
DHIC 
It has been shown that HSF-1 plays an important role in promoting many beneficial 
effects such as thermotolerance and longevity in the insulin/IGF-like signaling pathway 
[2,68,108]. Similar to DAF-16, lifespan extension results from reduced DAF-2 activity is 
also HSF-1 dependent. HSF-1 is shown to be required for proper expression of many 
downstream genes, including a group of small heat-shock proteins, in the context of 
 
 48
DAF-2-mediated longevity [2]. Indeed, our data showed that the inactivation of the 
DAF-2 pathway leads to an overall increase in HSF-1 activity, as observed in the 
multi-step activation, including nuclear translocation, oligomerization, post-translational 
modification, DNA binding activity, and HSF-1 target gene expression (Figure 10 and 
Figure 11). These results support the idea that HSF-1 is subject to direct control by 
insulin/IGF-like signaling. 
 
Our study on the regulation of DHIC complex formation strongly suggested that DHIC 
might be, at least in part, responsible for HSF-1 regulation by insulin/IGF-like signaling. 
First, we observed that the formation of DHIC is reduced upon DAF-2 inactivation, 
indicating that insulin/IGF-like signaling may modulate protein-protein interaction among 
DHIC components (Figure 20D). Moreover, our data pointed out a possibility that DAF-2 
activity may modulate the formation of DHIC through affecting the phosphorylation on 
DDL-1. The phosphorylation of DDL-1 T182 may attenuate the interaction between 
HSF-1 and DDL-1 (i.e. formation of DHIC), whereas the dephosphorylation of DDL-1 
T182 promotes the formation of DHIC. We concluded that T182 may play a role in the 
insulin/IGF-like signaling regulated HSF-1 activation. 
 
2-5-4 Multiple Layers of Regulation of HSF-1 Activity 
The activation of HSF-1 in response to heat or other types of stressors is 
well-established in many systems. Our study suggested that HSF-1 activity is not only 
controlled by stress induction, but also subject to direct regulation by the insulin/IGF-like 
signaling. Comparing the effects of stress stimulation, which acts in a transient and 
dramatic fashion, hormonal stimulation usually involves in long-term regulation. As 
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observed in our co-immunoprecipitation experiment, the modulation of DHIC formation 
by insulin/IGF-like signaling do not seemed to be affected by heat stress (Figure 21B), 
suggesting that the DAF-2 pathway regulates DHIC in a molecular mechanism 
independent of canonical heat-shock-induced HSF activation pathway. Although it 
remains possible that chronic stress may indirectly modulate HSF-1 activity through 
affecting hormonal pathways including the insulin/IGF-like signaling, we concluded that 
the insulin/IGF-like signaling/DHIC-mediated HSF-1 regulation is unlikely to be 
responsible for immediate, acute stress-induced HSF-1 activation. We believe that 
insulin/IGF-like signaling may act as a modulatory pathway that regulates the level of 
stress-susceptible (inducible) HSF-1, thereby fine-tuning stress response. 
 
2-5-5 Model of HSF-1 Activation Regulated by insulin/IGF-like signaling in C. 
elegans 
In C. elegans, modulation of the insulin/IGF-like signaling pathway is a pivotal 
determinant of the endocrine control of many physiological processes such as growth, 
reproduction, metabolism, longevity, as well as stress response. HSF is a master 
transcription factor previously known to be required for stress response and homeostasis, 
and has been postulated to act downstream of insulin/IGF-like signaling to mediate 
longevity. In this chapter, we have demonstrated that HSF-1 is subject to direct 
regulation by insulin/IGF-like signaling, and this regulation occurs via the modulation of 
the formation of DHIC, an HSF-1 inhibitory complex. 
 
Upon heat stress stimulation, HSF-1 undergoes oligomerization, posttranslational 
modification, and nuclear translocation in an undefined order before acquiring DNA 
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binding and transcriptional activity. The formation of a DDL-1-containing HSF-1 inhibitory 
complex (DHIC), consisting of HSF-1, HSB-1, DDL-1, and DDL-2, reduces the pool of 
HSF-1 susceptible to heat stress stimulation. We proposed that increased 
insulin/IGF-like signaling promotes the formation of DHIC, whereas reducing 
insulin/IGF-like signaling activity promotes DDL-1 phosphorylation, disrupts DHIC 







Figure 10. Inactivation of DAF-2 positively regulates HSF-1 activity and heat-shock response [3] 
(A) Nuclear accumulation of HSF-1 in response to insulin/IGF-like signaling inactivation. EQ73 animals 
(hsf-1::gfp) grown on vector control (VC) or different RNAi bacteria were unstressed or heat shocked for 
30 min (HS) before being classified into three groups according to the nuclear/cytosolic (n/c) ratio of GFP 
intensity in the intestinal cells (right). “c,” “wn,” and “sn” are animals with n/c ratio < 1.2, 1.2∼2.0, and > 2.0, 
respectively. The means of three independent experiments were pooled and shown (left). ∗p < 0.0001 
versus VC under same conditions (chi2 test). n ≥ 300. (B) The result of a representative experiment of 
DNA binding activity of HSF-1 in daf-2(e1370) mutants in response to 90 min of heat shock (HS). (C) The 
mean ± SD of three independent experiments in (B) (mean ± SD), normalized to the control (N2 with 
unlabeled HSE). (D and E) N2 or daf-2 RNAi animals were unstressed or heat shocked for 90 min (HS). 
Worm whole-cell extracts (WCE) of these animals were subjected to immunoblot analysis using 






Figure 11. Quantitative RT-PCR analysis of hsf-1, hsp-16.2, sip-1, and hsp-70s expression [3] 
(A) The mRNA level of hsf-1 is not affected by daf-2 knockdown. Relative abundance of hsf-1 mRNA in 
animals fed with vector control, daf-2 or hsf-1 RNAi bacteria with or without heat-shock. The mRNA levels 
were measured by quantitative RT-PCR. “HS” indicates that the animals were shifted to 37°C for 90 
minutes before they were collected. In all cases, the relative mRNA levels were normalized against the 
internal control act-1 (β -actin) and compared to the unstressed vector control (= 1). The data for at least 
three independent experiments were pooled, and the mean ± SD of each treatment is shown. ∗p < 0.05 
when compared to the unstressed vector control. The differences in hsf-1 mRNA level between control 
and daf-2(RNAi) animals both under HS conditions were not statistically significant, however. (B-E) 
Relative abundance of (B) hsp-16.2, (C) hsp-70 (F44E5.5), (D) sip-1 and (E) hsp-70 (C12C8.1) mRNA in 
wild-types (N2) or daf-2(e1370) mutants fed with control or hsf-1 RNAi bacteria. The mRNA levels were 
measured by quantitative RT-PCR. “HS” indicates that the animals were shifted to 37°C for 90 minutes 
before they were collected. The inset shows the mRNA level under unstressed conditions (without 
90 minutes HS). Data were combined from at least three experiments, and the mean ± SD of each 




Figure 12. Effects of altering ddl-1 and ddl-2 expression on longevity and stress response [3] 
(A and B) Reduction of ddl-1 or ddl-2 expression results in increased resistance to heat and oxidative 
stresses. N2 animals grown on vector control (blue), ddl-1 RNAi (green), or ddl-2 RNAi (orange) bacteria 
were exposed to different types of environmental stressors. The viability of these animals was then scored
every 2-4 hr. (A) For the thermotolerance analysis, animals were shifted to 35°C. (B) For the oxidative 
stress analysis, animals were exposed to 300 mM paraquat. (C) Lifespan analysis of wild-type (N2), 
ddl-1(ok2916), ddl-2(ok3235) and hsb-1(cg116) mutant animals at 20°C. (D and E) Overexpression 
of ddl-1 and ddl-2 failed to produce significant longevity phenotypes.(D) Lifespan analysis of wild-type 
animals (N2, blue) and animals overexpressing HA::ddl-1 (EQ136, red) at 20°C.(E) Lifespan analysis of 
wild-type animals (N2, blue) and animals overexpressing FLAG::ddl-2 (EQ106, red) at 20°C. (F) The 
lifespan-extending effect of ddl-1(ok2916) mutation is abolished by overexpressing HA-tagged DDL-1. 
Lifespan analysis of N2 animals, ddl-1(ok2916) mutants, or transgenic animals overexpressing 
hsf-1::gfp in ddl-1(ok2916) background (EQ187) at 20°C. Statistical details were summarized in Table 2 






Figure 13. DDL-1 and DDL-2 negatively regulate mRNA expression of 
HSF-1 downstream targets [3] 
Relative abundance of (A) hsp-16.2, (B) hsp-70 (F44E5.5), (C) sip-1 and 
(D) hsp-70 (C12C8.1) mRNA in N2, hsf-1(RNAi), ddl-1(RNAi), or 
ddl-2(RNAI) animals with or without heat shock (90 min). The inset shows 
the mRNA level under unstressed conditions. The means ± SD of three 





Figure 14. DDL-1 and DDL-2 negatively regulate nuclear translocation, DNA binding, and 
post-translational modification of HSF-1 [3] 
(A) Nuclear accumulation of HSF-1 in response to DDL-1/2 inactivation. EQ73 animals (hsf-1::gfp) grown 
on control, ddl-1, or ddl-2 RNAi bacteria were unstressed or heat shocked for 30 min (HS). The results of 
three experiments were pooled and shown here. Data are mean, n ≥ 300 per RNAi treatment. ∗p < 
0.0001; #p = 0.097 versus N2 under same conditions (chi2test). (B and C) Lowering ddl-1 or ddl-2 
expression increases HSF-1 DNA binding activity. The DNA binding activity of HSF-1 in N2, ddl-1(RNAi), 
or ddl-2(RNAi) animals was measured by EMSA before or after 90 min of heat shock (HS). A 
representative experiment is shown in (B). Quantification of three independent experiments (mean ± SD) is
presented in (C). (D and E) Worm whole-cell extracts (WCE) prepared from N2, ddl-1(RNAi), 
or ddl-2(RNAi) animals with or without 90 min of HS were subjected to immunoblot analysis using 
anti-HSF-1 (top) or anti-β-actin (bottom) antibodies. Detailed quantification is shown in (E). (F) The mRNA 
level of hsf-1 is not affected by ddl-1 or ddl-2 RNAi knockdown. Relative abundance of hsf-1 mRNA in 
animals fed with vector control, ddl-1 or ddl-2 RNAi bacteria with or without heat-shock. ∗p < 0.05 when 
compared to the unstressed vector control. The differences in hsf-1 mRNA level between control 









Figure 15. The expression pattern of ddl-1 in C. elegans [3] 
Transgenic lines expressing a translational GFP fusion (ddl-1p::ddl-1::gfp) of DDL-1 have been utilized to 
analyze the expression pattern of ddl-1 in C. elegans. (A–D) Images of transgenic animals expressing 
GFP-tagged DDL-1 driven by the endogenous ddl-1 promoter. DDL-1::GFP expression can be found 
primarily in the cytoplasm of intestinal cells, pharyngeal cells, and a number of neuronal cells in the head and







Figure 16. The expression pattern of ddl-2 in C. elegans [3] 
Images of transgenic animals (EQ104) carrying a ddl-2p::ddl-2::gfp array.(A–F) Expression of DDL-2::GFP
is found in several neurons located throughout the body. The neurons that express ddl-2 might include six 
touch receptor neurons (AVM, ALM, PVM, PLM), motor neuron HSN, interneuron AVH, and ALA.(G) 
Occasional expression of DDL-2 in one adult intestinal cell. It is estimated that about 15%–20% of 





Figure 17. A common hsf-1-dependent mechanism mediates the longevity effects of ddl-1, ddl-2, 
and hsb-1 [3] 
(A) Lifespan analysis of wild-type (N2) animals or hsf-1(sy441) mutants grown on empty vector control 
or ddl-1 RNAi bacteria at 20°C. (B) Lifespan analysis of N2 animals or hsf-1(sy441) mutants grown on 
control or ddl-2 RNAi bacteria at 20°C.(C) Lifespan analysis of N2 animals or hsb-1(cg116) mutants 
grown on control or hsf-1 RNAi bacteria at 20°C. (D) Lifespan analysis of N2, ddl-1(ok2916), 
hsb-1(cg116), or ddl-1(ok2916);hsb-1(cg116) mutants at 20°C. (E) Lifespan analysis of 
N2, ddl-2(ok3235), hsb-1(cg116), or ddl-2(ok3235);hsb-1(cg116) mutants at 20°C. (F) Lifespan analysis 
of N2, ddl-1(ok2916), ddl-2(ok3235) or ddl-1(ok2916); ddl-2(ok3235) mutants at 20°C. Statistical details 






Figure 18. DDL-1 forms a protein complex with HSF-1, HSB-1, and DDL-2 in mammalian cells and 
C. elegans [3] 
(A) DDL-1 interacts with DDL-2 in 293T cells. Here and in (B) and (C), 293T cells were transfected with 
indicated combinations of pCMV-HA-DDL-1, pFLAG-CMV2-DDL-2, pFLAG-CMV2-DDL-1, 
pCMV-Myc-HSB-1, or pCMV-Myc-HSF-1 plasmids. Whole-cell extracts were then immunoprecipitated 
(IP) and subsequently western blotted (WB) using indicated antibodies. (B) DDL-1 interacts with HSB-1 
in 293T cells. (C) DDL-1 may form a protein complex with HSF-1 in 293T cells. (D) DDL-1 forms a protein 
complex with HSF-1 in C. elegans. Worm whole-cell extracts (WCE) were prepared from N2, EQ136 
(HA-ddl-1 o.e.), or EQ193 [HA-ddl-1 o.e.; hsb-1(cg116)] animals. Samples were immunoprecipitated and 
subsequently western blotted using indicated antibodies. (E) DDL-1 interacts with DDL-2 in C. elegans. 
WCE were prepared from N2 or EQ155 animals expressing both HA-DDL-1 and FLAG-DDL-2 proteins. 




Figure 19. DDL-1/HSB-1 bimolecular fluorescence complementation assay (BiFC) 
(A and C) Animals expressing MalE::VN173 and HSB-1::VC155 as negative control. MalE encodes a 
bacterial maltose binding protein that has no known molecular interaction with eukaryotic proteins. These 
animals produced minimal fluorescence signal. (B and D) Animals expressing DDL-1::VN173 and 





Figure 20. Both the formation of DHIC and the threonine phosphorylation of DDL-1 are regulated by
insulin/IGF-like signaling [3]  
(A) Whole-cell extracts prepared from 293T cells overexpressing HA-DDL-1 were treated with buffer or 
1 U/μg protein CIP (calf intestinal alkaline phosphatase) for 1 hr. Samples were then subjected to western 
blot analysis (WB) with anti-HA antibodies. (B) Whole-cell extracts prepared from 293T cells 
overexpressing HA-tagged wild-type or mutated (T182A) DDL-1 were subjected to western blot analysis 
(WB) using anti-HA or anti-phosphothreonine antibodies. (C) The level of threonine-phosphorylated DDL-1
is elevated in daf-2 mutants. WCE prepared from N2 or EQ136 worms grown on control or daf-2 RNAi 
bacteria were immunoprecipitated and western blotted using indicated antibodies. (D) The formation of 
DHIC is disrupted by insulin/IGF-like signaling inactivation. Worm whole-cell extracts (WCE) prepared from
N2 or EQ136 (HA-ddl-1 o/e) adult animals grown on control, daf-2, akt-1, or a 1:1 mixture 
of daf-2 and daf-16 RNAi bacteria were subjected to immunoprecipitation (IP) and western blot analysis 
(WB) with indicated antibodies. The total HSF-1 input of each IP experiment was measured by blotting 
each WCE sample with anti-HSF1 antibodies. Quantitation is shown in (Figure 21A) (E) 293T cells were 
transfected with indicated combinations of pCMV-driven HA-DDL-1(WT), HA-DDL-1(T182A), or 
Myc-HSF-1 plasmids. Whole-cell extracts prepared from these cells were immunoprecipitated (IP) and 
subsequently western blotted (WB) using indicated antibodies. (F) Interaction between DDL-1 and DDL-2 
is not affected by T182A mutation. 293T cells were transfected with the indicated combinations of 
HA-DDL-1(WT), HA-DDL-1(T182A) or Flag-DDL-2 plasmids. Protein extracts prepared from these cells 






Figure 21. The formation of DHIC is altered by insulin/IGF-like signaling, HSB-1 level, but not heat 
stress [3] 
(A and B) Worm whole cell extracts (WCE) were prepared from synchronized day 1 N2, transgenic 
EQ136 [HA-ddl-1 OE], or EQ193 [HA-ddl-1 OE in hsb-1(cg116) background] adult animals grown on 
vector control, daf-2, akt-1, or a 1:1 mixture of daf-2 and daf-16 RNAi bacteria. Animals were either 
unstressed (-) or heat-shocked (+) at 37°C for 90 min (HS) before being harvested. WCE were then 
subjected to immunoprecipitation with anti-HA antibodies and Western-blotting with anti-HSF antibodies. 
The total HSF-1 input of each IP experiment was measured by blotting each WCE sample with anti-HSF1
antibodies. At least three independent experiments were performed and representative immunoblots are 
presented in Figure 20D. Shown here is relative HSF-1 level (mean ± SD) pulled down together with 
HA-DDL-1. The relative HSF-1 levels were normalized against total HSF-1 input and compared to the 
EQ136 empty vector control (= 100). ∗p < 0.0001; ∗∗p < 0.005 when compared to the control under the 
same stress conditions. The difference between daf-2(RNAi); daf-16(RNAi) and daf-2(RNAi) treatments 
is not statistically significant (p = 0.08). The difference between stressed (HS) or unstressed animals 









Figure 22. ddl-1 T182A mutation minimally impacts DAF-2 longevity 
Lifespan analysis of wild-type (N2), ddl-1(ok2916) mutant, and ddl-1 rescue animals grown on empty 
vector control or daf-2 RNAi bacteria at 20°C. Statistics are summarized in Table 3. 
 
 
Figure 23. DDL-1 phospho-threonine level is not diminished by 
gska-3, gsk-3 and akt-1 inhibition [3] 
Quantitation of threonine phosphorylated DDL-1 
in daf-2(RNAi), akt-1(RNAi), gska-3(RNAi) and gsk-3(RNAi) 
animals. Shown here are relative levels (mean ± SD of at least 
three independent experiments) of threonine phosphorylated 
DDL-1 in WCE samples prepared from synchronized day 1 
adult EQ136 or EQ97 (HA:ddl-1) worms fed with control or the 
indicated RNAi bacteria. WCE were immunoprecipitated with 
anti-phospho-threonine antibodies and Western-blotted with 
anti-HA antibodies. The relative pT182-DDL-1 levels were 
normalized against total DDL-1 input and compared to the 
empty vector control (= 100). ∗p < 0.01 when compared to the 










Table 1.  
Strain 
Mean Lifespan 




P Value n 
N2; control (i) 17.2 ± 0.3 21 − 67/90 
N2; ddl-1(RNAi) (i) 19.1 ± 0.3 22 0.0034a 84/90 
hsf-1(sy441); control 14.9 ± 0.1 16 <0.0001a 101/169 




N2; control (ii) 17.2 ± 0.2 20 − 63/82 
N2; ddl-2(RNAi) (ii) 19.2 ± 0.2 22 0.0008a 68/86 
hsf-1(sy441); control 13.6 ± 0.2 15 <0.0001a 86/156 




N2; control (iii) 19.1 ± 0.2 22 − 62/72 
N2; hsf-1(RNAi) 11.2 ± 0.2 12 <0.0001a 46/72 
hsb-1(cg116); control 30.0 ± 0.4 35 <0.0001a 74/84 




N2 17.1 ± 0.5 22 − 68/72 
ddl-1(ok2916) 22.6 ± 0.2 26 <0.0001a 49/72 
ddl-2(ok3235) 23.2 ± 0.3 26 <0.0001a 65/72 




N2 (i) 18.9 ± 0.2 22 − 60/72 
ddl-1(ok2916) 25.1 ± 0.3 27 <0.0001a 65/72 
hsb-1(cg116) (i) 30.3 ± 0.5 35 <0.0001a 62/72 




N2 (ii) 17.1 ± 0.4 21 − 52/72 
ddl-2(ok3235) 22.6 ± 0.3 26 <0.0001a 32/72 
hsb-1(cg116) (ii) 26.8 ± 0.4 32 <0.0001a 32/72 
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N2; control (RNAi) (iv) 17.2 ± 0.6 23 − 82/90 
N2; ddl-1(RNAi) (iv) 21.3 ± 0.5 25 0.0006a 81/90 
N2; ddl-2(RNAi) (iv) 21.4 ± 0.6 28 0.0001a 81/90 
N2; ddl-1(RNAi); ddl-2(RNAi) 20.9 ± 0.3 25 <0.0072a, 0.34g, 0.26h 86/90 
N2; control (RNAi) (iv) 16.8 ± 0.4 19 − 61/71 
N2; ddl-1(RNAi) (iv) 22.3 ± 0.3 25 0.0001a 65/75 
N2; ddl-2(RNAi) (iv) 23.5 ± 0.2 25 0.0001a 66/72 





Table 1. Effects of ddl-1, ddl-2, and hsb-1 mutations on lifespan [3] 
Adult mean lifespan ± SEM in days. Lifespan experiments were carried out at 20°C. The 75th 
percentile is the age at which the fraction of animals alive reaches 0.25. “n” shows the number of 
observed deaths relative to total number of animals started. The difference between these 
numbers represents the number of animals censored. Animals that exploded, bagged, or crawled 
off the plates were censored at the time of the event. The log rank (Mantel-Cox) test was used for 
statistical analysis (p values). 
 
a p values calculated by pairwise comparisons to N2 grown on vector control of the same 
experiment. 
b Compared to N2 grown on the same RNAi bacteria. 
c Compared to the same mutants grown on vector control. 
d Compared to ddl-1(ok2916) mutants. 
e Compared to hsb-1(cg116) mutants. 
f Compared to ddl-2(ok3235) mutants. 
g Compared to N2 grown on the ddl-1 RNAi bacteria of the same experiment. 











P Value n 
(i) Thermotolerance         
N2; control (i) 16.2 ± 0.3 18 − 60 
N2; ddl-1(RNAi) (i) 19.9 ± 0.2 22 <0.0001a 63 
N2; ddl-2(RNAi) (i) 20.9 ± 0.2 22 <0.0001a 62 
N2; control (i) 16.6 ± 0.2 18 − 90 
N2; ddl-1(RNAi) (i) 20.6 ± 0.3 24 <0.0001a 90 
N2; ddl-2(RNAi) (i) 21.2 ± 0.3 24 <0.0001a 90 
hsf-1(sy441); control (i) 14.8 ± 0.4 16 <0.0001a 90 
hsf-1(sy441); ddl-1(RNAi) (i) 14.8 ± 0.3 16 0.38c 90 
hsf-1(sy441); ddl-2(RNAi) (i) 15.2 ± 0.2 17 0.29c 90 
(ii) Oxidative stress         
N2; control (i) 19.1 ± 0.2 5 − 43 
N2; ddl-1(RNAi) (i) 11.2 ± 0.2 9 <0.0001a 50 
N2; ddl-2(RNAi) (i) 30.0 ± 0.4 11 <0.0001a 49 
N2; control (i) 17.1 ± 0.5 6 − 90 
N2; ddl-1(RNAi) (i) 22.6 ± 0.2 10 <0.0001a 90 
N2; ddl-2(RNAi) (i) 23.2 ± 0.3 8 <0.0001a 90 







P Value n 
N2; control(RNAi) 16.5 ± 0.3 20 − 67/81 
N2; ddl-1(RNAi) 18.4 ± 0.2 20 <0.0067a 71/92 
hsf-1(sy441; control(RNAi) 13.5 ± 0.2 15 <0.0001a 85/106 




N2; control(RNAi) 17.2 ± 0.1 19 − 68/90 
N2; ddl-1(RNAi) 19.5 ± 0.1 21 <0.0001a 80/90 
hsf-1(sy441; control(RNAi) 13.1 ± 0.2 16 <0.0001a 94/120 
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N2; control(RNAi) 18 ± 0.3 21 − 67/90 
N2; ddl-2(RNAi) 20.2 ± 0.3 23 0.0003a 81/95 
hsf-1(sy441); control(RNAi) 14.9 ± 0.2 16 <0.0001a 101/130 




N2; control(RNAi) 17.2 ± 0.1 19 − 68/90 
N2; ddl-2(RNAi) 19.9 ± 0.1 23 <0.0001a 85/90 
hsf-1(sy441); control(RNAi) 13.1 ± 0.2 16 <0.0001a 94/120 




N2; control(RNAi) 18.5 ± 0.2 21 − 73/84 
N2; hsf-1(RNAi) 11.2 ± 0.2 14 <0.0001a 59/84 
hsb-1(cg116); control(RNAi) 29.6 ± 0.5 37 <0.0001a 75/84 




N2; control(RNAi) 18.8 ± 0.2 22 − 72/84 
N2; hsf-1(RNAi) 10.4 ± 0.2 12 <0.0001a 65/84 
hsb-1(cg116); control(RNAi) 31.1 ± 0.5 37 <0.0001a 54/84 




N2 19.0 ± 0.5 22 − 68/72 
ddl-1(ok2916) 23.4 ± 0.3 26 <0.0001a 66/72 
hsb-1(cg116) 29.1 ± 0.5 36 <0.0001a 57/72 




N2 18.2 ± 0.3 22 − 74/80 
ddl-1(ok2916) 24.1 ± 0.2 26 <0.0001a 75/80 
hsb-1(cg116) 30.8 ± 0.4 34 <0.0001a 73/80 




N2 19.5 ± 0.4 22 − 71/77 
 
 69
ddl-2(ok3235) 24.0 ± 0.2 25 <0.0001a 65/78 
hsb-1(cg116) 27.8 ± 0.3 32 <0.0001a 58/78 




N2 17.1 ± 0.5 22 − 71/77 
ddl-2(ok3235) 21.8 ± 0.3 25 <0.0001a 65/78 
hsb-1(cg116) 26.2 ± 0.5 32 <0.0001a 58/78 




N2 16.8 ± 0.4 22 − 71/77 
ddl-2(ok3235) 22.3 ± 0.3 25 <0.0001a 65/78 
hsb-1(cg116) 23.5 ± 0.2 32 <0.0001a 58/78 






Table 2. Effects of ddl-1, ddl-2, and hsb-1 mutations on stress resistance and lifespan [3] 
For stress resistance analysis (i-ii), N2 animals grown on vector control, ddl-1 RNAi, or ddl-2 
RNAi bacteria were exposed to heat (35°C) or oxidative stress (300 mM paraquat). Mean survival 
SEM, in hours, observed in the stress analysis was shown in the table. 75th percentile is the time 
at which the fraction of animals alive reaches 0.25. ‘n’ indicates the number of animals scored in 
the each experiment. For lifespan analysis, the experiments were carried out at 20°C. All 
experiments were repeated 3 times (shown in Table 1 and here). Each set of repetitions was 
carried out independently and shown here in separate groups. 75th percentile is the age at which 
the fraction of animals alive reaches 0.25. ‘n’ shows the number of observed deaths relative to 
total number of animals started at day 1. The difference between these numbers represents the 
number of animals censored during the experiment.  
 
a p-Values calculated by pair-wise comparisons to N2 grown on vector control of the same 
experiment.  
b p-Values calculated by pair-wise comparisons to N2 grown on the same RNAi bacteria.  
c p-Values calculated by pair-wise comparisons to the same mutants grown on vector control.  
d p-Values calculated by pair-wise comparisons to ddl-1(ok2916) mutants.  
e p-Values calculated by pair-wise comparisons to hsb-1(cg116) mutants.  
f p-Values calculated by pair-wise comparisons to ddl-2(ok3235) mutants.  
 
We used Stata 8 software for statistical analysis and to determine means and percentiles. The 
logrank (Mantel-Cox) test was used to test the hypothesis that the survival functions among 
groups were equal. 
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P Value n 
N2 16.2 ± 0.3 19 - 61/71 
hsf-1::gfp (OE) 22.1 ± 0.3 25 <0.0001a 62/69 
myc::hsf-1  (OE) 21.0 ± 0.2 24 <0.0001a 63/72 
N2 19.6 ± 0.3 22 - 75/80 
hsf-1::gfp (OE) 24.5 ± 0.4 29 <0.0001a 73/80 
myc::hsf-1 (OE) 23.8 ± 0.5 29 <0.0001a 76/80 
N2 15.9 ± 0.5 21 - 51/58 
hsf-1(sy441) 13 ± 0.2 15 0.0001a 52/89 
hsf-1(sy441);hsf-1::gfp (OE) 19 ± 0.4 23 0.0006a, <0.0001b 79/91 
N2 17.4 ± 0.5 21 - 79/83 
hsf-1(sy441) 12.5 ± 0.2 15 0.0001a 64/83 
hsf-1(sy441);hsf-1::gfp (OE) 19.5 ± 0.4 23 0.027a, <0.0001b 71/81 
N2 19.6 ± 0.3 22 − 61/72 
HA::ddl-1(OE) 19.7 ± 1.0 26 0.028a 66/72 
N2 17.1 ± 0.6 21 − 52/72 
Flag::ddl-2(OE) 17.8 ± 0.6 21 0.47a 60/72 
N2 18.9 ± 0.4 22 − 60/72 
HA::ddl-1(OE);Flag::ddl-2(OE) 16.9 ± 0.6 20 0.059a 62/72 
N2 21.6 ± 0.5 28 − 56/72 
HA::ddl-1(OE) 20.2 ± 0.6 28 0.67a 65/72 
Flag::ddl-2(OE) 21.2 ± 0.7 28 0.71a 62/72 
N2 19.8 ± 0.4 22 − 70/90 
HA::ddl-1(OE) 19.1 ± 0.5 24 0.71a 66/76 
Flag::ddl-2(OE) 18.3 ± 0.5 22 0.21a 61/75 
HA::ddl-1(OE);Flag::ddl-2(OE) 18.2 ± 0.5 22 0.21a 59/90 
N2 19.9 ± 0.4 23 − 61/73 
ddl-1(ok2916) 24.8 ± 0.3 28 <0.0001a 57/70 
ddl-1(ok2916); HA::ddl-1(OE) 19.5 ± 0.5 25 0.62a 65/72 
N2 20.0 ± 0.5 24 − 60/72 
ddl-1(ok2916) 24.4 ± 0.3 28 <0.0001a 63/72 
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ddl-1(ok2916); HA::ddl-1(OE) 19.5 ± 0.6 24 0.90a 64/72 
N2; control (RNAi) 21.0 ± 0.5 26 − 58/72 
N2; daf-2(RNAi) 48.3 ± 1.4 65 <0.0001a 47/72 
ddl-1(ok2916); daf-2(RNAi) 45.1 ± 1.6 65 <0.0001a 51/72 
ddl-1(ok2916); HA::ddl-1(OE); daf-2 
(RNAi) 
45.9 ± 1.0 61 <0.0001a, 0.7836c 53/84 
ddl-1(ok2916); HA::ddl-1 T182A(OE); 
daf-2(RNAi) 
42.4 ± 1.6 58 







Figure 10: All data were performed by Dr. Tsui-Ting Ching. 
Figure 11 and Figure 13: RT-PCR experiments were performed by Dr. Hee-Chul Lee. 
Figure 14 A-C: HSF-1 nuclear translocation assay are performed by Dr. Ao-Lin Hsu and 
EMSA were performed by Dr. Tsui-Ting Ching. 
Figure 19: Photographs were taken by Dr. Tsui-Ting Ching. 
 
Table 3. Effects of ddl-1, ddl-2, and hsf-1 overexpression on lifespan [3] 
Adult mean lifespan SEM, in days, observed in lifespan analysis. Lifespan experiments were 
carried out at 20°C. 75th percentile is the age at which the fraction of animals alive reaches 
0.25. ‘n’ shows the number of observed deaths relative to total number of animals started at day 
1. The difference between these numbers represents the number of animals censored during 
the experiment. All experiments were repeated at least 2 times. Each set of repetitions was 
carried out independently and shown here in separate groups.  
 
a p-Values calculated by pair-wise comparisons to N2 control of the same experiment.  
b p-Values calculated by pair-wise comparisons to hsf-1(sy441) mutants.  
c p-Values calculated by pair-wise comparisons to ddl-1(ok2916); daf-2 RNAi animals 
d p-Values calculated by pair-wise comparisons to ddl-1(ok2916); HA-ddl-1(OE); daf-2 RNAi 
animals 
 
We used Stata 8 software for statistical analysis and to determine means and percentiles. The 
logrank (Mantel-Cox) test was used to test the hypothesis that the survival functions among 





Chapter 3.  C. elegans SIRT6/7 homolog SIR-2.4 promotes  
DAF-16 relocalization and function during stress†. 
 
3-1 Abstract 
FoxO transcription factors and sirtuin family deacetylases/ADP-ribosyl-transferases 
regulate diverse biological processes, including stress responses, metabolism and 
longevity. We show that the C. elegans sirtuin SIR-2.4 – a homolog of the mammalian 
SIRT6 and SIRT7 proteins – is required for stress responses to heat shock, oxidative 
insult, and proteotoxicity. It has been previously known that multiple stresses promote 
nuclear translocation and activation of FoxO transcription factor DAF-16, which directs 
the transcriptional program controlling metabolism, longevity, and stress resistance. In 
this study, we found that SIR-2.4 is required for stress-induced DAF-16 nuclear 
localization and DAF-16 dependent gene expression, indicating that SIR-2.4 may play an 
important role in modulating DAF-16 function in response to stress. 
 
We investigated the mechanism by which SIR-2.4 regulates DAF-16 activity. Surprisingly, 
deacetylase/ADP-ribosyltransferase catalytic activity of SIR-2.4 is not required for 
DAF-16 nuclear accumulation under stress conditions. Our biochemical analysis showed 
that the level of CBP-dependent DAF-16 acetylation is inhibited by both wild-type and 
catalytic null SIR-2.4 mutant, indicating that SIR-2.4 modulates DAF-16 indirectly. We 
                                                 
† The data from this chapter has been published in: Chiang et. al., C. elegans SIRT6/7 homolog 
SIR-2.4 promotes DAF-16 relocalization and function during stress. PLoS Genet 8: e1002948. 
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also found evidence to suggest that SIR-2.4 may modulate DAF-16 activity by blocking 
the CBP-dependent DAF-16 acetylation. Overall, our findings establish an important role 
for SIR-2.4 in regulating DAF-16 upon stress, and demonstrate a novel mechanism by 
which SIR-2.4 and CBP modulate DAF-16 activity under stress conditions. 
 
3-2 Introduction 
Sirtuins comprise an evolutionally conserved family of proteins that possess histone 
deacetylase and mono-ribosyltransferase activity. This class of proteins is known to 
function in the regulation of diverse biological processes including longevity, stress 
response, metabolism, and cancer. Acetylation is an important way to modulate protein 
functions. Similar to phosphorylation, acetylation of a protein can alter its function (e.g., 
DNA binding, transcriptional activity, protein stability, localization, and enzyme activity). 
Sirtuins are a class of protein deacetylases that catalyze the removal of acetyl groups 
from lysine residues, although it is recently found that some sirtuins do not act as 
deacetylase . Unlike many other deacetylases, such as class I, IIA, IIB and IV histone 
deacetylases (HDACs), sirtuins require NAD+. The dependence of NAD+ links sirtuin 
activity to cellular energy status, via the ratio of NAD+/NADH. Indeed, recent studies 
have shown that sirtuins act as key metabolic sensors that directly link nutritional status 
and environment signals to metabolic homeostasis [109]. Although sirtuins were 
originally identified as histone deacetylases, the deacetylation of histones is not the only 
mechanism for sirtuins to modulate cellular functions. Various mammalian transcription 
factors have been shown to be the substrates of sirtuins. In many cases, deacetylation of 





As previously suggested, sirtuin genes are involved in the regulation of longevity in yeast, 
flies, worms, and likely in mice [55-58], indicating an evolutionally ancient role of sirtuins 
in longevity assurance. Extension of lifespan by overexpressing sirtuins was first 
reported in yeast. Soon after, similar effects were also observed in flies and worms. In 
yeast, the strain carrying duplicated copy of the SIR2 gene showed around a 30% 
increase in lifespan. In flies, overexpression of dSIR2 leads to lifespan extension up to 
57%. In worms, overexpression of sir-2.1 leads to increased longevity in a 
daf-16-dependent manner. However, some of these findings have recently been 
challenged [59,110]. It has been found that lifespan extension by sirtuins overexpression 
in flies and worms was the result of genetic background. Thus, the role of sirtuins in 
longevity regulation in flies and worms remains controversial. 
 
Recent studies indicate that sirtuin may mediate the beneficial effect of caloric restriction, 
a dietary regime known to promote longevity in many organisms ranging from yeast to 
mammals [111-113]. Sirtuins have been linked to the insulin/IGF signaling pathway to 
regulate FoxO activity in many systems. In mammals, SIRT1 has been shown to activate 
FoxO during oxidative stress [60]. SIRT2 is known to regulate FoxO activity to inhibit 
adipocyte differentiation [61,62]. Both SIRT1/2 are known to directly deaceylate FoxO. 







In C. elegans, there are four putative sirtuin-like genes, SIR-2.1 to SIR-2.4. SIR-2.1 has 
been shown to regulate metabolism and stress response. While SIR-2.1 has been 
extensively studied, very little is known about the biological functions and characteristics 
of other worm sirtuins. In this study, we attempted to characterize the function of SIR-2.4, 
a homolog of mammalian SIRT6/7 (Figure 25). SIRT6 has been implicated in DNA repair, 
metabolism and aging. SIRT6-deficient cells showed increased sensitivity to certain 
forms of genotoxic damage and increased genome instability. Mice lacking SIRT6 have 
prominent metabolic defects including hypoglycemia, low insulin, and low IGF1 levels, 
while possessing degenerative syndrome mimicking models of accelerated aging [114]. 
In this study, we found that SIR-2.4 plays a key role in promoting resistance against heat, 
oxidative and proteotoxic stress. SIR-2.4 is required for a proper onset of stress-induced 
DAF-16 nuclear translocation and activation. The overexpression or inactivation of 















Figure 25. Phylogenetic classification of C. elegans and mammalian sirtuins [4] 
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role in the insulin/IGF-like signaling-mediated DAF-16 nuclear accumulation, longevity, 
and dauer formation. Overall, our findings suggested that SIR-2.4 primarily functions in 
stress response and is largely independent of the DAF-2 pathway. Further analysis 
showed that SIR-2.4 regulates DAF-16 through blocking CBP (CREB-binding 
protein)-dependent DAF-16 acetylation through a catalytic activity-independent manner. 
Together, these findings demonstrated that SIR-2.4 is a critical mediator of stress 
responses through a DAF-16-dependent pathway, and revealed a novel mechanism by 
which sirtuins regulate FoxO functions. 
 
 
3-3 Material and Methods 
C. elegans Strains 
CF1041: daf-2(e1370)III,  
TJ356: zIs356 [daf-16::gfp + rol-6],  
AM140: rmIs132[unc-54p::Q35::yfp],  
MT18068: sir-2.4(n5137)I,  
EQ137: iqEx47 [sir-2.4p::sir-2.4::gfp + rol-6],  
EQ158: iqEx50 [sir-2.4p::sir-2.4 + myo-3p::rfp],  
EQ200: sir-2.4(n5137)I; zIs356 [daf-16::gfp + rol-6],  
EQ205: sir-2.4(n5137)I; zIs356 [daf-16::gfp + rol-6]; iqEx59 
[sir-2.4p::sir-2.4NA + myo-3p::rfp],  
EQ211: sir-2.4(n5137)I; zIs356 [daf-16::gfp + rol-6]; iqEx60 
[sir-2.4p::sir-2.4 + myo-3p::rfp].  
All strains used were maintained and handled as described previously [115]. TJ356, 
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AM140 and CF1041 were obtained from the Caenorhabditis Genetic Center. For the 
generation of transgenic animals, plasmid DNA mixes were injected into the gonad of 
young adult hermaphrodite animals, using the standard method described previously. F1 
progeny were selected on the basis of the roller phenotype. Individual F2 progenies were 
isolated to establish independent lines. For the generation of the EQ137 (SIR-2.4::GFP 
overexpressor) strain, plasmid DNA containing a mixture of 100 ng/μl of 
sir-2.4p::sir-2.4::gfp and 50 ng/μl of pRF4 (rol-6) constructs was injected into N2 animals. 
For the generation of EQ158 (native SIR-2.4 overexpressor), plasmid DNA containing a 
mixture of 30 ng/μl of native sir-2.4 driven by its own promoter and 50 ng/μl of coinjection 
marker myo-3p::rfp was injected into N2 animals. For the generation of EQ211, plasmid 
DNA containing a mixture of 30 ng/μl of sir-2.4p::sir-2.4 and 80 ng/μl of myo-3p::rfp 
constructs was injected into TJ356 animals. For the generation of EQ205, plasmid DNA 
containing a mixture of 30 ng/μl of sir-2.4p::sir-2.4NA and 80 ng/μl of myo-3p::rfp 
constructs was injected into TJ356 animals. 
 
RNA-interference (RNAi) Experiments 
HT115 bacteria transformed with RNAi vectors (L4440) expressing dsRNA of the genes 
indicated were grown at 37ºC in LB with 10 mg/ml tetracycline and 50 mg/ml carbenicillin, 
then seeded onto NG-carbenicillin plates and supplemented with 100 μl 0.1M IPTG. The 
sir-2.4 RNAi construct was generated by cloning nucleotides 1-467 of the sir-2.4 cDNA 
into the L4440 vector. The identity of all RNAi clones was verified by sequencing the 
inserts using M13 forward primer. Eggs were added to plates and transferred to new 




sir-2.4 Deletion Mutant Analysis 
The deletion in a sir-2.4 mutant strain (kind gift of the Horvitz laboratory) was mapped by 
PCR, and found to encompass 1,929 bp of chromosome I (5990775-5992703), which 
encodes nucleotides 28-879 of the SIR-2.4 (C06A5.11) spliced mRNA. 
 
DAF-16 Nuclear Localization Assay 
For quantification of DAF-16::GFP localization, synchronized eggs from TJ356 animals 
(i.e. transgenic animals expressing DAF-16::GFP) or other strains as indicated were 
seeded onto either vector control or appropriate RNAi plates. For stress response 
experiments, day 1 adults were washed with M9 three times and transferred to new 20 
plates or and subjected to heat shock (35C) or oxidative stress (1.5 mM H2O2 in M9). 
GFP localization was then analyzed using an Olympus BX61 fluorescent microscope at 
40x or 100x magnification. For time-course analysis, worms were scored for the 
presence or absence of GFP accumulation within the nuclei of head hypodermis cells 
(n= 30~50) in a blinded fashion every 5-30 min. An animal was scored as having nuclear 
GFP if more than one head hypodermic nucleus contained DAF-16::GFP. For single time 
point experiments, worms were blindly scored for the presence or absence of GFP 
accumulation within the nuclei of indicated cells (n = 120 or greater). P values were 
calculated by Poisson regression (time-course assays) or chi-square test (single time 
point assays). 
 
Quantitative RT-PCR Analysis 
Total RNA was isolated from approximately 5,000 day 1 adult worms, and cDNA was 
generated from 5 μg of RNA using Superscript III RT (Invitrogen). Real-time qRT-PCR 
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experiments were performed using the Power SYBR Green PCR Master mix (Applied 
Biosystems) and the Chromo 4 system (MJ Research). Relative mRNA level of the 
genes of interest were calculated and normalized against an internal control (act-1; worm 
β-actin). Primer sequences were (all 5’-3’):  
sod-3 (GTTTCAGCGCGACTTCGGTTCCCT, CGTGCTCCCAAACGTCAATTCCAA); 
dod-3 (AAAAAGCCATGTTCCCGAAT, GCTGCGAAAAGCAAGAAAAT);  
dod-24 (TGTCCAACACAACCTGCATT, TGTGTCCCGAGTAACAACCA);  
C32H11.4 (TTACTTCCCATCGCCAAAGT, CAATTCCGGCGATGTATGAT);  
hsp-16.1 (GATCAAAAGTTTGCCATAAATCTC, TTCAGTCTTTAATTCTTGTTCTCC);  
ins-7 (TCGTTGTGGAAGAAGAATACATTC, TTAAGGACAGCACTGTTTTCG); and  
act-1 (CTACGAACTTCCTGACGGACAAG, CCGGCGGACTCCATACC). 
 
Stress Assay 
For thermotolerance assays, eggs from N2 worms were transferred to plates seeded 
with vector control, daf-16 RNAi, or sir-2.4 RNAi bacteria and grown to day 1 of 
adulthood. Worms were then transferred to plates without any food and heat-shocked at 
35C. Viability was determined at the indicated time points; death was determined by the 
lack of movement after prodding. For oxidative stress assays, eggs from N2 worms were 
transferred to plates seeded with vector control, daf-16 RNAi, or sir-2.4 RNAi bacteria 
and grown to day 3 of adulthood. Worms were then transferred to 24-well plates and 
soaked in 1.5 mM H2O2 in M9 media. Viability was determined at the indicated timepoints 
as above. For stress assays, a Kaplan−Meier survival analysis with a log-rank test was 





Synchronized eggs from AM140 animals (i.e. transgenic animals expressing Q35::YFP) 
were seeded on either vector control or the indicated RNAi bacteria. Animals were 
scored for polyQ-induced paralysis every other day during adulthood. Paralyzed worms 
were identified as those failing to make forward or backward movement in response to 
stimulation by plate-tapping and tail-prodding; these worms still exhibited pharyngeal 




Lifespan analysis were conducted at 20°C as described previously [100,116]. Strains 
were grown at 20°C for at least two generations without starvation prior to lifespan 
analysis. At least 72 worms were used for each experiment. In all experiments, the 
pre-fertile period of adulthood was used as t = 0 for lifespan analysis. Stata 9 software 
was used for statistical analysis to determine the means and percentiles. In all cases, 
P-values were calculated using the log-rank (Mantel-Cox) method. 
 
Assessment of DAF-16 Acetylation in Worms 
~15,000 synchronized day 1 adult worms grown at 20ºC were harvested by washing 
three times with cold M9 buffer with 0.01% Triton X-100 and once with HB-high salt 
buffer (10 mM HEPES, pH 7.9; 10 mM KCl; 1.5 mM MgCl2; 0.1 mM EDTA; 0.5 mM 
EGTA; 44 mM Sucrose; 100 mM NaCl; 0.5 % Triton X-100). Worm pellets were then 
resuspended in 3X volume of HB-high salt buffer supplemented with Protease Inhibitor 
Cocktail Complete (Roche), 20 mM β-glycerophosphate, 1 mM sodium orthovanadate, 1 
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mM nicotinamide and 1 μM trichostatin A. Pellets were immediately frozen and stored in 
liquid nitrogen. Frozen suspensions were thawed, homogenized with a Dounce 
homogenizer (30 strokes with pestle B), and centrifuged at 14,000xg at 4 ºC for 20 
minutes. Supernatants were collected and total protein concentrations were quantified 
by Bradford assay. For immunoprecipitation, 30 μl of anti-acetyl-lysine agarose beads 
(Immunechem; ICP0388) were added to 1 mg of protein extract with 100 g/ml of 
ethidium bromide and incubated with gentle shaking at 4ºC overnight. The beads were 
then washed 3 times with HB-high salt buffer supplemented with 50 mg/ml ABESF, 1 
mM sodium orthovanadate, 1 mM nicotinamide and 1 μM trichostatin A. before being 
subjected to western blot analysis. The samples were subjected to SDS-PAGE and 
transferred to a PVDF membrane (Millipore). The membrane was washed three times 
with TBS containing 0.1% Tween 20 (TBST). After blocking with TBST containing 5% 
nonfat milk for 60 min, the membrane was incubated with the primary antibody indicated 
(e.g. anti-GFP, Abcam, #AB6556) at 4°C for 12 h and washed three times with TBST. 
The membrane was then probed with HRP-conjugated secondary antibody for 1 h at 
room temperature and washed with TBST three times. Finally, the immunoblots were 
developed using a chemiluminescent substrate (Millipore) and visualized by 
autoradiography. 
 
Assessment of SIR-2.4/DAF-16 Interaction 
10 cm dishes of HEK293T cells were transfected using TransIT-293 (Mirus) with 
plasmids encoding HA-tagged DAF-16 (1 μg), FLAG-tagged SIR-2.4 (9 μg), both 
DAF-16 and SIR-2.4 plasmids together, or a plasmid encoding GFP (5 μg), to assess 
transfection efficiency. Cells were harvested 48 hours post transfection, and were lysed 
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by rotation at 4C for 20 minutes in lysis buffer (LB; 150 mM NaCl, 1% Triton X-100, 
0.5% NP40, 50 mM Tris pH 7.4, 10% glycerol, with Protease Inhibitor Cocktail 
Complete-EDTA free (Roche), followed by brief sonication. 1 mg of whole cell extract 
from each cell line was pre-cleared by slow rotation with 50 l of protein G conjugated 
agarose beads. For immunoprecipitation, either 25 μl of M2-agarose beads (Sigma) 
(anti-FLAG IP) or 25 l of anti-HA-agarose beads (Roche) (anti-HA IP) was added to 
pre-cleared WCE, and IPs were incubated overnight by slow rotation at 4C. After 
incubation, beads were pelleted and washed three times in LB. FLAG-tagged proteins 
were eluted in 80 μl of FLAG elution buffer (150 ng/μl 3xFLAG peptide (Sigma), 10 mM 
Tris-HCl (pH 8.0) and 150 mM NaCl) at 4C for 4 hours. 40 l of eluate was loaded on an 
SDS-PAGE gel. For HA IPs, 80 μl of Laemmli buffer was added to the anti-HA-agarose 
beads, and beads were boiled at 100C for 5 minutes; 40 μl was loaded on a gel. 
DAF-16 and SIR-2.4 interaction was assessed by immunoblot using anti-DAF-16 (Santa 
Cruz) or anti-HA antibodies. 
 
In vitro DAF-16 Acetylation Assay 
3xFLAG tagged DAF-16, CBP or SIR-2.4 were each transfected and expressed in 293T 
cells. These proteins were then purified with Anti-FLAG M2 Affinity Gel (Sigma, A2220). 
0.5 μg of purified DAF-16 was incubated with 0.2 μg of purified CBP with or without 0.5 
μg of purified SIR-2.4 in the presence of HAT buffer (50 mM Tris-HCl, pH 8.0, 0.1 mM 
EDTA, 1 mM dithiothreitol, 10% glycerol) supplemented with 200 μM of acetyl-CoA. The 
reactions were incubated at 37ºC for 3 hours and analyzed by western blot. Acetylated 
DAF-16 was queried with anti-acetyl-lysine antibody (Immunechem; ICP0380) and total 





3-4-1 SIR-2.4 promotes DAF-16 nuclear translocation and function 
Previous studies in mammals showed that FoxO activity is subject to regulation by 
sirtuins. We therefore tested the potential role of SIR-2.4 in DAF-16 subcellular 
localization and function. We created RNAi construct expressing dsRNA of sir-2.4 cDNA 
(generated by Bo Yang in Dr. David Lombard’s lab) and tested the effect of SIR-2.4 
inactivation in wild-type N2 animals. Under basal conditions, inactivation of SIR-2.4 by 
RNAi had no obvious effect on DAF-16::GFP localization. However, sir-2.4 knockdown 
led to a significant decrease in DAF-16::GFP nuclear translocation upon both oxidative 
and heat stress (Figure 26A and B), indicating that stress-induced DAF-16 nuclear 
translocation is impaired by the inactivation of SIR-2.4. We also verified this phenotype 
with a mutant carrying sir-2.4(n5137) allele. This mutant allele contains a deletion that 
encompasses almost the entire sir-2.4 open reading frame, leaving only nine N-terminal 
amino acids of SIR-2.4 open reading frame. This strain is viable and has no 
distinguishable morphological defects. Similar to sir-2.4 RNAi knockdown, sir-2.4 
deletion did not alter DAF-16::GFP localization in unstressed conditions, but showed 
apparent defect in stress-induced DAF-16::GFP translocation (Figure 26C). In addition, 
we noticed that in either sir-2.4 RNAi or deletion mutants, DAF-16 did eventually 
translocate into the nucleus after prolonged stress exposure, indicating that inactivation 
of SIR-2.4 delays but does not prevent stress-induced DAF-16 translocation.  
 
To verify this observation, we scored for DAF-16::GFP nuclear translocation on sir-2.4 
deletion animals at different time points following stress induction. Time-course 
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experiments showed that sir-2.4 deletion resulted in a right-shifted stress response curve 
upon oxidative stress (Figure 26 D, p<0.001 by Poisson regression analysis) and heat 
shock (Figure 26E, p<0.001), confirming that the inactivation of SIR-2.4 delays the onset 
of stress-induced DAF-16::GFP nuclear translocation. This finding implies that SIR-2.4 
may play a crucial role in modulating DAF-16 nuclear translocation, particularly at an 
early phase of stress response. 
 
DAF-16 is a transcription factor known to regulate the expression of many genes that 
function in longevity, metabolism, and stress response. To investigate whether SIR-2.4 
regulates DAF-16 function, we examined the mRNA expression level of two groups of 
genes previously identified as DAF-16 targets: class I (positively regulated by DAF-16) 
and class II (negatively regulated by DAF-16) by quantitative RT-PCR. SIR-2.4 
knockdown by RNAi led to a decreased level in mRNA expression of class I genes 
(sod-3, hsp-16.1 and dod-3) under both stress and non-stress conditions (Figure 27, top). 
Conversely, class II genes (dod-24, C32H11.4 and ins-7) showed a significant increase 
in mRNA expression in sir-2.4 knockdown animals (Figure 27, bottom) under both 
conditions. These findings suggested that DAF-16 transcriptional activity is subject to 
regulation by SIR-2.4. 
 
3-4-2 SIR-2.4 is required for resistance against multiple stressors 
DAF-16 is a well-known regulator for stress response [117-119]. The transcriptional 
targets of DAF-16 includes a large number of genes playing a critical role in cellular 
response to heat-shock response, oxidative damage, as well as innate immunity against 
bacterial infection. Thus, we tested whether the inactivation of SIR-2.4 would have any 
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effect on stress resistance. We challenged sir-2.4 knockdown or deletion worms with 
heat-shock (35°C) or oxidative insult (1.5 mM H2O2) and monitored their survival. As 
compared to wild-type animals, sir-2.4 knockdown or deletion rendered these animals 
considerably more sensitive to heat or oxidative stress (Figure 28A and B, Table 4). 
Moreover, simultaneous inhibition of daf-16 and sir-2.4 produced stress sensitivity to the 
extent similar to that of daf-16 alone (Figure 28A and B), suggesting that DAF-16 and 
SIR-2.4 may function in the same pathway to modulate stress resistance. Interestingly, 
neither sir-2.4 overexpressing nor RNAi knockdown animals showed altered longevity 
phenotype (Figure 28D and Figure 30A). We concluded that SIR-2.4 is required for 
stress resistance in a DAF-16-dependent manner but does not play a role in longevity 
determination. 
 
Progressive accumulation of aggregation-prone proteins and global collapse of the 
protein homeostasis (proteostasis) network are featured in many late-onset 
neurodegenerative disorders. In C. elegans, the DAF-2/DAF-16 pathway has been 
shown to play an essential role in maintaining proteostasis and protects animals from 
aggregation-associated proteotoxicity. Thus, we asked whether SIR-2.4 is required to 
maintain proper proteostasis. Proteotoxicity induced by a polyglutamine 
repeat-containing protein was examined by using the worms expressing fluorescent 
protein-tagged polyQ35 in body wall muscle (unc-54p::Q35::YFP). The expression of 
Q35 in body wall muscle cells led to age-dependent paralysis and an increase in the 
number of non-soluble aggregates. Consistent to the role of DAF-2/DAF-16 in 
modulating proteostasis, daf-2 RNAi animals showed considerably delayed onset of 
paralysis, whereas daf-16 RNAi animals showed accelerated progression (Figure 28C). 
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Similar to daf-16, we found that the inactivation of sir-2.4 by RNAi resulted in an early 
onset of paralysis. Taken together, all these data suggested that SIR-2.4 is required for 
proper response against multiple types of stress, including heat-shock, oxidative insult, 
and proteotoxicity. 
 
3-4-3 Tissue expression pattern of SIR-2.4 
To understand whether SIR-2.4 is required in a specific tissue, or whether SIR-2.4 acts in 
a cell-autonomous fashion, we attempted to determine the expression pattern of SIR-2.4. 
Transgenic lines overexpressing SIR-2.4 translational fusion (sir-2.4p::sir-2.4::gfp) 
(created by Dr. Bo Yang) were utilized to analyze the expression pattern of SIR-2.4. In 
general, we found that SIR-2.4 is expressed in most tissues, although the expression 
level is relatively weak. Higher expression was observed in a subset of head and tail 
neurons and some somatic gonad (spermathecal-uterine valve) cells (Figure 29). 
 
3-4-4 SIR-2.4 is dispensable for DAF-16 regulation in the context of 
insulin/IGF-like signaling 
In C. elegans, insulin/IGF-like signaling is known to modulate longevity and stress 
response in a DAF-16-dependent fashion. To ask whether SIR-2.4 is important in 
DAF-16 regulation in the context of reduced insulin/IGF-like signaling, we examined the 
effect of SIR-2.4 inactivation on longevity, DAF-16 nuclear translocation, and dauer 
formation in the context of reduced DAF-2 signaling. We found that sir-2.4 RNAi 
knockdown had no lifespan phenotype on N2 (wild-type) and did not suppress longevity 
in daf-2(e1370) animals (Figure 30A). The knockdown or deletion of sir-2.4 minimally 
impacted DAF-16 nuclear translocation induced by daf-2 RNAi (Figure 30B and 25C). 
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We also measured the formation of dauer diapause, a physiological process modulated 
by insulin/IGF-like signaling. The inactivation of sir-2.4 minimally impaired dauer 
formation on daf-2 RNAi-sensitized animals (Figure 30D). These data clearly indicated 
that the role of SIR-2.4 in regulating DAF-16 function is largely independent of 
insulin/IGF-like signaling. 
 
3-4-5 SIR-2.4 regulates DAF-16 acetylation and function independent of its 
catalytic activity 
Other members of the mammalian sirtuin family including SIRT1, SIRT2 and SIRT3 were 
previously shown to deacetylate FoxO [42,44,61,62,64,120,121]. SIR-2.4 is predicted to 
possess deacetylase activity; however, whether SIR-2.4 functions as a deacetylase to 
regulate DAF-16 has never been examined. It has been proposed that the modulation of 
FoxO acetylation status plays an important role in regulating FoxO function and activity; 
however, the acetylation of DAF-16 has never been demonstrated. Given the role of 
SIR-2.4 in regulating DAF-16 localization and function, we next examined whether 
SIR-2.4 affects the level of DAF-16 acetylation by in vitro assays, in collaboration with Dr. 
Daniel Tishkoff and Dr. Bo Yang.  
 
Our result indicated that DAF-16 is acetylated. The level DAF-16 acetylation is elevated 
in sir-2.4 knockdown or deletion animals (Figure 31A and B). Moreover, 
co-immunoprecipitation experiments indicated an interaction between SIR-2.4 and 
DAF-16 in mammalian cells (Figure 31D), implying that SIR-2.4 may directly deacetylate 
DAF-16. To test whether the catalytic activity of SIR-2.4 is required for DAF-16 
deacetylation, we performed in vitro SIR-2.4 deacetylase assay. Purified wild-type 
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SIR-2.4 and SIR-2.4 N124A, a predicted catalytic null mutant based on homology, were 
incubated with pre-acetylated DAF-16 as substrate. We were unable to detect DAF-16 
deacetylation by either wild-type SIR-2.4 or SIR-2.4 N124A (data not shown). It is 
possible that the buffer used is not optimized for SIR-2.4, and SIR-2.4 may require other 
additional factors to be fully active in vitro.  
 
Thus, we tested the requirement of SIR-2.4 catalytic activity directly in C. elegans by 
analyzing stress-induced DAF-16 translocation. The results showed that sir-2.4 deletion 
strongly impacted DAF-16 nuclear translocation, whereas the overexpression of SIR-2.4 
in sir-2.4 deletion background rescued mutant defect (Figure 31E, SIR-2.4KO + SIR-2.4). 
To our surprise, the overexpression of SIR-2.4 N124A, a predicted catalytic-null mutant, 
rescued this defect as efficiently as wild-type SIR-2.4 (Figure 31E, SIR-2.4KO + 
SIR-2.4NA), indicating that SIR-2.4 catalytic activity is not required for promoting 
stress-induced DAF-16 translocation. Unfortunately, we were not able to confirm DAF-16 
acetylation level in SIR-2.4 overexpressing animals by biochemical analysis, as the 
worms carrying chromosomal integrated daf-16 and sir-2.4 transgenes are very sick and 
produce few progeny. Overall, these data led to the conclusion that SIR-2.4 regulates 
DAF-16 activity independent of its catalytic activity, potentially through a mechanism that 
recruits other DAF-16 deacetylases or prevents the action of other DAF-16 
acetyltransferses. 
 
3-4-6 SIR-2.1 does not play a major role in stress-induced DAF-16 nuclear 
translocation 
Chromatin modifying complex contains multiple enzymes, including histone 
 
 89
deacetylases. These proteins share common enzymatic activity and have been shown to 
possess redundant function to some extent. Based on this observation, we considered a 
possibility that SIR-2.4 collaborates with other sirtuins or non-sirtuin deacetylases to 
modulate DAF-16 localization and function. Given the role of SIR-2.1 in DAF-16 
activation suggested previously [122], potential collaboration between SIR-2.1 and 
SIR-2.4 was tested. We first examined the interaction between SIR-2.1 and SIR-2.4 by 
co-immunoprecipitation in cell culture. To eliminate potential association through 
chromatin-associated complexes, cell extracts were co-immunoprecipitated with the 
presence of ethidium bromide (EtBr), a DNA intercalating agent that disrupts 
protein-DNA interactions. We observed strong physical interaction between SIR-2.1 and 
SIR-2.4 (Figure 32A). The presence of EtBr did not disrupt the association, suggesting 
that the interaction between SIR-2.1 and SIR-2.4 occurs through protein-protein 
interactions. 
 
We next examined whether SIR-2.1 plays a role in regulating DAF-16 nuclear 
translocation upon stress. Our data showed that sir-2.1 knockdown by RNAi had little 
effect on DAF-16 nuclear translocation upon either oxidative stress (Figure 26D, p=0.72) 
or heat-shock (Figure 26E, p=0.44). This result indicated that SIR-2.1 does not play a 
major role in stress-induced DAF-16 nuclear translocation, consistent with previously 
published data [123]. Moreover, inactivation of sir-2.1 in sir-2.4(n5137) mutant animals 
did not result in any further delay in stress-induced DAF-16 nuclear translocation (Figure 
26D and E). These findings suggested that it is unlikely that SIR-2.1 and SIR-2.4 




However, our biochemical assays indicated that sir-2.1 knockdown caused a modest 
increase in DAF-16 acetylation (Figure 31C), indicating that SIR-2.1 may still 
deacetylates DAF-16, similar to its mammalian ortholog SIRT1. Simultaneous 
inactivation of SIR-2.1 and SIR-2.4 resulted in a strong increase in DAF-16 acetylation to 
an extent similar to SIR-2.4 inactivation alone (Figure 31C), suggesting that SIR-2.1 and 
SIR-2.4 may impact common DAF-16 acetylation site(s). The fact that SIR-2.1 itself does 
not possess strong effect on stress-induced DAF-16 nuclear translocation and 
acetylation raised a possibility that the SIR-2.1-dependent acetylation may not play a 
significant role in stress-dependent DAF-16 localization and function. Thus, we 
concluded that despite the fact that SIR-2.1 does physically interact with SIR-2.4, 
SIR-2.1 does not collaborate with SIR-2.4 to modulate stress-induced DAF-16 function. 
 
3-4-7 CBP-1 and SIR-2.4 acts antagonistically to affect DAF-16 localization 
To ask whether SIR-2.4 prevents DAF-16 acetylation by blocking the acetylation site or 
by preventing the action of an acetyltransferase, we screened for known 
acetyltransferase(s) that affects DAF-16::GFP localization. We examined five putative C. 
elegans acetyltransferases genes: cbp-1 (p300/CBP), pcaf-1 (p300/CBP-associated 
factor), mys-1, mys-2 and mys-4 (MYST histone acetyltransferases). Worms fed on 
cbp-1 RNAi displayed robust nuclear DAF-16 translocation even under basal conditions 
(Figure 33A), whereas animals fed on pcaf-1, mys-1, mys-2 and mys-4 RNAi did not 
show any significant effects under the same condition. 
 
CBP (CREB-binding protein)/p300 is known to play a critical role in development, 
homeostasis, and transcriptional regulation. It contains intrinsic histone acetyltransferase 
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activity and has been shown to acetylate histone and non-histone proteins. Although 
p300/CBP has been shown to regulate FoxOs via acetylation in mammals [124], its 
C.elegans ortholog, CBP-1, has not been well characterized in the context of DAF-16 
regulation. Our data indicated that the effect of CBP-1 and SIR-2.4 in regulating DAF-16 
localization is largely antagonistic, as sir-2.4 deletion strongly impaired cbp-1 
RNAi-induced DAF-16 nuclear localization (Figure 33A). Consistent with the idea of 
CBP-1 as an acetyltransferase for DAF-16, we found that cbp-1 RNAi knockdown 
resulted in a modest but detectable reduction in DAF-16 acetylation level (Figure 33B). 
 
In principle, if cbp-1 RNAi promotes DAF-16 nuclear translocation, we would expect that 
cbp-1 RNAi-mediated DAF-16 nuclear accumulation leads to a beneficial effect on 
longevity and stress resistance. On the contrary, we observed that cbp-1 knockdown led 
to hypersensitivity to heat-shock and oxidative stress and a shortened lifespan (Figure 
33C and D). Although it seemed contradictory to the role of CBP-1 in modulating DAF-16 
localization, this observation is consistent with the previously published results [125]. 
The inhibition of cbp-1 might not be beneficial for longevity and stress resistance, as 
constitutive nuclear accumulation of DAF-16 may be insufficient for proper DAF-16 
activation. In addition, since CBP-1 has crucial role in regulating the expression of many 
genes functioning in diverse biological processes, we do not rule out the possibility that 
the optimum expression of certain essential genes is greatly perturbed by the 
inactivation of cbp-1. 
 
3-4-8 SIR-2.4 blocks CBP-dependent DAF-16 acetylation 
To ask whether SIR-2.4 prevents p300/CBP-dependent DAF-16 acetylation, Dr. Tishkofff 
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performed the in vitro CBP acetylation assay by co-incubating purified DAF-16 and CBP 
with and without SIR-2.4 protein. The presence of SIR-2.4 greatly diminished the level of 
CBP-mediated DAF-16 acetylation (Figure 33E). A SIR-2.4 catalytic null mutant (H124Y) 
appeared to exert a similar effect on DAF-16 (Figure 33E, SIR-2.4NA), suggesting that 
SIR-2.4 inhibits CBP-dependent DAF-16 acetylation through a mechanism independent 
of its catalytic activity. This result suggested two possible mechanisms by which SIR-2.4 
prevents CBP-dependent DAF-16 acetylation: (1) SIR-2.4 binds to DAF-16 and thereby 
blocks CBP-1 action; and (2) SIR-2.4 inhibits the enzymatic activity of CBP-1 
independent of deacetylase activity.  
 
3-4-9 Identification of DAF-16 acetylation sites 
To reveal a potential mechanism by which SIR-2.4 prevents CBP-dependent DAF-16 
acetylation, we attempted to identify potential CBP-1 acetylation sites on DAF-16 in 
collaboration with Dr. Steven Gygi’s lab at Harvard University. Recombinant DAF-16 
were expressed and acetylated by CBP in vitro, and mass-spectrometry analysis was 
performed. We identified four CBP-1-dependent acetylation sites on DAF-16: K248, 
K253, K375, and K379. Notably, acetylation on K248 is also present on mammalian 
FoxO1 (K262) and FoxO3A (K259), implying a potential common mechanism in which 
CBP regulates FoxO/DAF-16 function. To further examine the functional impact of these 
acetylation sites on DAF-16, future studies such as creating transgenic animals carrying 
DAF-16 acetylation deficient or mimetic mutations and assessing their effect on DAF-16 







3-5-1 SIR-2.4 modulates stress-dependent DAF-16 localization and function 
In this chapter, we demonstrated a crucial role for SIR-2.4 in the stress response against 
heat, oxidative and proteotoxic stress (Figure 28A-C). We found that SIR-2.4 affects the 
kinetics of the DAF-16 nuclear translocation and activation (Figure 26D and E). SIR-2.4 
neither affects longevity, nor plays a significant role in insulin/IGF-like signaling-mediated 
DAF-16 nuclear accumulation, longevity, and dauer formation (Figure 30A-D). Overall, 
our findings suggested that SIR-2.4 primarily functions in stress resistance and is largely 
independent of the DAF-2 pathway. Interestingly, we found that the catalytic activity of 
SIR-2.4 is not required for the regulation of stress-induced DAF-16 nuclear translocation 
(Figure 31E). Further analysis revealed that SIR-2.4 prevents CBP-dependent DAF-16 
acetylation (Figure 33E), likely through a protein-protein interaction. Together, we 
revealed a novel mechanism by which SIR-2.4 indirectly modulates DAF-16 localization 
and function in response to stress. 
 
Despite the fact that sirtuins were found to directly deacetylate and modulate FoxO 
function in mammals, whether this activity is also conserved in C. elegans has never 
been confirmed. In this study, we demonstrated for the first time that DAF-16 is 
acetylated (Figure 31A-C), and the modulation of DAF-16 acetylation may be critical for 






3-5-2 SIR-2.1 and SIR-2.4 may play distinct role in regulating DAF-16 function 
SIR-2.1 is reported to modulate DAF-16 activity to promote longevity (although this is 
currently disputed). However, according to our data and previous observations [123], 
SIR-2.1 seemed to have a much less prominent role in promoting stress-induced 
DAF-16 nuclear accumulation (Figure 26D and E). On the other hand, SIR-2.4 does not 
affect longevity (Figure 28D), appears to function largely independently of the 
insulin/IGF-like signaling pathway (Figure 30A), but plays a crucial role in regulating 
DAF-16 nuclear translocation and survival in the context of stress (Figure 26D and E). 
Together, our observations suggested differential physiological functions for SIR-2.1 and 
SIR-2.4. These two sirtuins may play distinct roles in modulating different aspects of 
DAF-16 function.  
 
As previously mentioned, our biochemical data showed that SIR-2.1 inactivation 
modestly increased DAF-16 acetylation, whereas SIR-2.4 inactivation had a much 
stronger effect (Figure 31C). Simultaneous inactivation of both SIR-2.1 and SIR-2.4 
resulted in an increase of DAF-16 acetylation similar to that of SIR-2.4 alone, suggesting 
that SIR-2.1 and SIR-2.4 may influence common acetylation site(s). Since SIR-2.4 
inactivation led to a much stronger increase in DAF-16 acetylation than SIR-2.1, it is 
conceivable that SIR-2.4 plays a much more prominent role in modulating DAF-16 
acetylation. As shown previously, SIR-2.1 and SIR-2.4 mutants displayed distinct 
phenotypes in longevity and stress response; thus, it is likely that SIR-2.1- and 
SIR-2.4-dependent acetylation modulate diverse functions of DAF-16. However, whether 
the individual or combination of these residue(s) contributes to SIR-2.1- or 




3-5-3 Catalytic activity-independent functions of sirtuins 
Previous studies have shown that the neuroprotective effect of SIRT1 is achieved 
through a catalytic-independent mechanism that protects neurons from low-potassium 
induced apoptosis and promotes cell survival [126]. SIRT1 was also shown to physically 
interact with DOT1, a histone H3K79 methylase and enhance DOT1 function in 
repressing α-ENaC (epithelian Na+ channel α-subunit) transcription independent of its 
deacetylase activity [126]. Similarly, our experiments showed that SIR-2.4 promotes 
stress-induced DAF-16 nuclear accumulation in a deacetylase-independent fashion 
(Figure 31E). These findings suggested that the molecular function of SIR-2.4 may 
include but may not be limited to deacetylation. Other sirtuins might also carry out some 
of their function through a similar deacetylase-independent mechanism. 
 
3-5-4 Antagonistic function of SIR-2.4 and CBP-1 in DAF-16 regulation 
FoxO transcription factors are known to interact with and be acetylated by p300/CBP in 
mammalian cells [63,124,127]. However in C .elegans, whether p300/CBP modulates 
DAF-16 function has not been reported. Our result showed that CBP-1 inactivation led to 
strong, constitutive nuclear accumulation under basal conditions (Figure 33A), 
suggesting a potent role for CBP-1 in promoting DAF-16 nuclear recruitment. Although 
CBP-1 can acetylate DAF-16 at multiple residues in vitro, we were only able to detect a 
modest decrease in the level of DAF-16 acetylation in cbp-1 RNAi animals (Figure 33B). 
We do not rule out the possibility of the presence of CBP-1-independent acetylation 
site(s), as well as compensations from other acetyltransferase(s) functionally redundant 
to CBP-1. In addition, since the anti-acetyl-lysine antibody used in western blot does not 
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well discriminate the number of acetylated lysine on DAF-16, it is possible that the actual 
difference between control and cbp-1 RNAi may be obscured by this technical limitation. 
 
Despite the fact that cbp-1 RNAi animals have constitutive nuclear DAF-16, our 
observations and previous report showed that these animals are stress sensitive and 
short lived (Figure 33C) [125]. It has been shown that DAF-16 constitutively localizes in 
the nucleus in long-lived, stress resistant daf-2 mutant animals [128-130]; however, 
nuclear accumulation per se may not be sufficient for proper DAF-16 activation, as 
mutation on AKT phosphorylation sites on DAF-16 leads to constitutive DAF-16 nuclear 
accumulation but does not promote longevity and dauer formation [25,130]. Therefore, 
DAF-16 nuclear entry induced by CBP-1-dependent acetylation may be required, but not 
sufficient for subsequent DAF-16 activation. In cbp-1 RNAi animals, nuclear 
accumulation of inactivated (or partially activated) DAF-16 may perturb gene expression 
by occupying binding sites at promoter regions or interacting with other factors, leading 
to a deleterious effect on longevity and stress resistance. Moreover, since CBP-1 is a 
multi-functional protein implicated in the transcriptional regulation of many biological 
pathways, it is likely that the expression of certain essential genes is greatly perturbed by 
CBP-1 inactivation. Nevertheless, our findings have demonstrated that CBP-1 plays a 
crucial role in DAF-16 nuclear accumulation. 
 
The proto-oncogene protein DEK has been shown to exert potent inhibitory effects on 
p300- and PCAF-mediated histone acetylation via protein-protein interaction [131]. We 
found that SIR-2.4 may pose its inhibitory effect on CBP-1-mediated DAF-16 acetylation 
through a similar mechanism. Our in vitro assay showed that the presence of SIR-2.4 
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greatly diminished the level of DAF-16 acetylation by CBP-1 (Figure 33E). The fact that 
SIR-2.4 prevents CBP-1 action through a catalytic-independent fashion rules out the 
possibility that SIR-2.4 inhibits CBP-1 activity through deacetylating CBP-1. Since 
SIR-2.4 and DAF-16 were found to physically interact in our co-immunoprecipitation 
experiment, it is likely that SIR-2.4 blocks CBP-1-dependent DAF-16 acetylation through 
a protein-protein interaction. 
 
3-5-5 Possible mechanism by which SIR-2.4/CBP-1 regulates stress-induced 
DAF-16 function 
We hypothesized that, under unstressed conditions, SIR-2.4 does not interact with 
DAF-16. This allows CBP-1 to directly acetylate DAF-16 and prevent DAF-16 nuclear 
translocation and function. Upon stress, SIR-2.4 binds to DAF-16, inhibits 
CBP-1-dependent acetylation, and promotes DAF-16 nuclear accumulation and 
subsequent activation (Figure 34). Alternatively, SIR-2.4 may directly bind to and inhibit 
CBP-1 activity. Overall, in order to further test these hypotheses, it will be necessary to 
examine the interactions among DAF-16, SIR-2.4 and CBP-1 in the context of basal and 
stress conditions in the future. 
 
We observed a significant reduction in DAF-16 acetylation level under oxidative stress 
conditions (Figure 32B), indicating that the DAF-16 acetylation status is regulated by 
stress. Our mass spectrometry analysis has identified four DAF-16 acetylation sites: 
K248, K253, K375, and K379. K248 is found to be homologous to mammalian FoxO 
acetylation site K262(FoxO1) and K259(FoxO3A). We do not know whether these sites 
are responsible for stress-induced DAF-16 acetylation and function. Thus, to further 
 
 98
understand whether these DAF-16 lysine residues regulate stress-induced DAF-16 
localization and function, future work will focus on examining whether SIR-2.4 prevents 
CBP-1-dependent acetylation on these residues, and whether these residues play a role 
in stress-dependent DAF-16 nuclear accumulation and function. In addition, it will also 
be interesting to explore the role of these acetylation sites(s) in regulating other divergent 
physiological functions of DAF-16. 
 
Taken together, we showed that SIR-2.4 plays a crucial role in regulating stress 
resistance and DAF-16 activity largely independent of insulin/IGF-like signaling pathway. 
SIR-2.4 is found to regulate DAF-16 acetylation and localization independent of its 
catalytic activity, indicating that SIR-2.4 may interact with other factor(s) to affect DAF-16 
function. Further analysis revealed that SIR-2.4 inhibits DAF-16 acetylation by 
preventing CBP-1-dependent DAF-16 acetylation, likely through a protein-protein 
interaction. We hypothesize that SIR-2.4 prevents CBP-1-dependent DAF-16 acetylation 
in a stress-dependent manner, thereby allowing subsequent DAF-16 nuclear 
translocation and activation. Although details regarding the proposed mechanism remain 
unclear and require further investigation, our study presented here provides important 








Figure 26. SIR-2.4 is required for proper onset of DAF-16 nuclear localization [1] 
TJ356 animals carrying an integrated daf-16::gfp array were fed either vector control or sir-2.4 RNAi 
bacteria for at least one generation before being subjected to heat-shock or oxidative stress. (A) Images of 
TJ356 animals grown on control or sir-2.4 RNAi bacteria after 15 min heat-shock. (B and C) Quantification 
of DAF-16::GFP nuclear accumulation in response to oxidative stress (1.5 mM H2O2 for 1 hr) or 
heat-shock (35°C for 15 min.). Worms were scored for the presence or absence of GFP accumulation 
within the intestinal nuclei (n = 120 or greater for all treatments). An animal was scored as having nuclear 
GFP if one or more intestinal nuclei contained DAF-16-GFP. (D and E) Time course analysis of 
DAF-16::GFP nuclear accumulation in response to stress. TJ356 (daf-16::gfp) or EQ200 
[sir-2.4(n5137); daf-16::gfp] animals grown on either control or sir-2.1 RNAi bacteria were subjected to (D) 
oxidative stress (1.5 mM H2O2) or (E) heat-shock (35°C) or. Worms were scored for GFP accumulation 







Figure 27. SIR-2.4 is required for optimal DAF-16–dependent gene expression [1] 
Wild-type N2 animals fed on either vector control or sir-2.4 RNAi bacteria from the time of hatching were 
exposed to 10 mM H2O2 for 80 min. Relative mRNA levels of sod-3, hsp-16.1, dod-3, dod-24, C32H11.4, 
and ins-7 were measured by quantitative RT-PCR and the means of three different sample sets are shown.
Relative mRNA levels were normalized against act-1 (beta-actin). Error bars: ± STD. Statistical 
significance as determined by two-tailed t-test is shown in the table below; significant differences are 







Figure 28. SIR-2.4 is required for stress resistance, but not longevity [1] 
(A) Wild-type N2 or sir-2.4(n5137) worms grown on vector control or daf-16 RNAi bacteria were subjected 
to heat-shock at 35°C and scored for viability every 1-2 hours. (B) Wild-type N2 or daf-16(mu86) worms 
grown on vector control or sir-2.4 RNAi bacteria were treated with 1.5 mM H2O2 and scored for viability 
every 1–2 hours. (C) AM140 worms expressing polyQ-containing protein (Q35::YFP) were seeded on the 
RNAi bacteria indicated and scored for polyQ induced paralysis every other day. (D and E) Lifespan of 
wild-type (N2) animals or transgenic animals overexpressing native SIR-2.4 (EQ158) at 20°C. (D) 
Thermotolerance assay. N2 and EQ158 were exposed to 35°C heat stress. Viability was then scored at the 





Figure 29. Expression pattern of sir-2.4 in C. elegans [1] 
Transgenic lines expressing a SIR-2.4 translational GFP fusion (sir-2.4p::sir-2.4::gfp) were utilized to analyze 
the expression pattern of sir-2.4 in C. elegans. Images of L3 (A and B) or late L4/young adult (C–E) stage 
transgenic animals (EQ137) expressing GFP protein under control of the sir-2.4 promoter. sir-2.4 is highly 
expressed in a subset of head and tail neurons beginning at early larval stage, indicated by white arrows. 
High expression of sir-2.4 is also found in spermathecal-uterine valve (sp-ut valve) cells beginning at L4 
larval stage, indicated by white arrows. The yellow arrow indicates the nuclear accumulation of SIR-2.4::GFP 
fusions in these cells. It is worth noting that very weak expression of sir-2.4 is found ubiquitously in most 





Figure 30. Minimal impact of SIR-2.4 on DAF-2 mediated longevity, DAF-16 nuclear localization, and
dauer formation [1] 
(A) Lifespan analysis of wild-type (N2) animals or daf-2(e1370) mutants grown on vector control bacteria 
(black or red) or sir-2.4 RNAi bacteria (green or blue) at 20°C. (B) DAF-16 nuclear localization was 
assessed in TJ356 (daf-16::gfp) or EQ200 (daf-16::gfp; sir-2.4(n5137)) animals. Animals were fed with 
either vector control or daf-2 RNAi from the time of hatching. Worms were scored for the presence or 
absence of GFP accumulation within the head hypodermic nuclei as day 1 adult (n = 116 or greater) under
unstressed condition. p-values were calculated by Pearson's chi-square test. (C)TJ356 animals were fed 
with either vector control, daf-2 RNAi, a 1:1 mix of daf-2 and sir-2.4 RNAi, or a 1:1 mix 
of daf-2 and yk615e RNAi bacteria from the time of hatching. yk615e is a gene randomly selected as a 
negative control in double RNAi experiments. Animals (n = 125 or greater) were scored for DAF-16::GFP 
nuclear translocation. (D) daf-2(e1370) mutants (P0) were fed with control or sir-2.4 RNAi bacteria at 20°C.
F1 eggs were then moved to 22°C for 72 hours prior to being scored for dauer formation (n = 336 or 






Figure 31. SIR-2.4 interacts with DAF-16 and promotes DAF-16 deacetylation and function 
independent of its catalytic activity [1] 
(A and B) sir-2.4 RNAi inactivation and deletion promote DAF-16 acetylation. DAF-16 acetylation was 
assessed in control, sir-2.4 deletion (KO) or RNAi worms by acetyl-lysine immunoprecipitation followed by 
GFP western blot. (C) DAF-16 acetylation was assessed in sir-2.4 deletion sir-2.1 RNAi, or double loss-of 
function animals as indicated. (D) SIR-2.4 and DAF-16 are interacted. Plasmids encoding FLAG-tagged 
SIR-2.4 and HA-tagged DAF-16 were transfected into 293T cells as indicated (GFP, negative control). 
Immunoprecipitation and western blot were performed as shown. (E) Rescue of DAF-16 nuclear 
localization with a catalysis-defective sir-2.4 mutant. Stable transgenic strains of sir-2.4(n5137) were 
generated expressing either wild-type SIR-2.4 or the sir-2.4 N124A mutant. Worms were scored for GFP 
accumulation within the head hypodermic nuclei as day 1 adult (n = 50 or greater) after 20 min of 








Figure 32.  
(A) SIR-2.4 and SIR-2.1 are physically interacted. Plasmids encoding FLAG-tagged SIR-2.4 and 
Myc-tagged SIR-2.1 were transfected into 293T cells as indicated. WCE were immunoprecipitated with or 
without the presence of 1μg/ml ethedium bromide (+/-EtBr). Immunoblots were performed as shown. The 
presence of EtBr did not reduce the amount of co-immunoprecipitated SIR-2.1, suggesting that the 
interaction between SIR-2.1 and SIR-2.4 does not occur through chromatin association. (B) Elevated level
of DAF-16 acetylation in response to oxidative stress. TJ356 (daf-16::gfp) worms were treated with 5 mM 
H2O2 for 20 minutes before harvest. DAF-16 acetylation was assessed by acetyl-lysine 







Figure 33. SIR-2.4 inhibits CBP1-mediated DAF-16 acetylation [1] 
(A) DAF-16 nuclear localization was assessed in TJ356 (daf-16::gfp) or EQ200 (daf-16::gfp; 
sir-2.4(n5137)). Animals (n = 90 or greater) were scored for DAF-16::GFP nuclear translocation as 
described in Figure 30B. (B) cbp-1 knockdown decreasesDAF-16 acetylation. DAF-16 acetylation was 
assessed in TJ356 worms grown on either control or cbp-1 RNAi by acetyl-lysine immunoprecipitation 
followed by GFP western blot. (C) cbp-1 inactivation confers stress sensitivity. Mean survival of cbp-1 
RNAi worms in response to peroxide stress (left) and heat shock (right). (D) cbp-1 inactivation leads to 
shortened lifespan. Lifespan curves of wild-type or sir-2.4 deletion animals in the presence of cbp-1 or 
control RNAi bacteria. (E) SIR-2.4 blocks CBP1-dependent DAF-16 acetylation in vitro. Purified tagged 
DAF-16 was incubated with CBP-1 in the presence of WT SIR-2.4 or the SIR-2.4 NA mutant at 37°C. 










Figure 34. Hypothesized Model 
We hypothesized that SIR-2.4 does not interact with DAF-16 under basal 
conditions. This allows CBP-1 to directly acetylate DAF-16 and prevent DAF-16 
nuclear translocation and function. Upon stress conditions, SIR-2.4 binds to 
DAF-16, inhibits CBP-1-dependent acetylation, perhaps by blocking K248, K253, 














P Value n 
N2, control * Heat-shock 12.05 ± 0.05 13 − 94/102 
N2, daf-16(RNAi) * Heat-shock 9.89 ± 0.10 11 <0.0001a 101/102
sir-2.4(n5137), control * Heat-shock 10.30 ± 0.11 11 <0.0001a 96/102 





N2, control Heat-shock 11.04 ± 0.08 12 − 102/120
N2, daf-16(RNAi) Heat-shock 9.46 ± 0.09 11 <0.0001a 109/120
sir-2.4(n5137), control Heat-shock 10.68 ± 0.06 11 <0.0228a 80/90 





N2, control * H2O2 10.31 ± 0.21 12 − 86/90 
N2, sir-2.4(RNAi) * H2O2 7.30 ± 0.24 8 <0.0001
a 88/90 
daf-16(mu86), control * H2O2 7.63 ± 0.21 10 <0.0001
a 89/90 





N2, control H2O2 10.96 ± 0.23 12 − 90/90 
N2, sir-2.4(RNAi) H2O2 8.95 ± 0.33 10 <0.0001
a 88/90 
daf-16(mu86), control H2O2 7.98 ± 0.23 10 <0.0001
a 86/90 





N2 Heat-shock 16.07 ± 0.20 18 − 79/84 
sir-2.4(n5137) Heat-shock 14.71 ± 0.17 16 <0.0001 79/84 
N2 H2O2 8.75 ± 0.09 8 − 72/72 
sir-2.4(n5137) H2O2 7.65 ± 0.11 8 <0.0001 72/72 
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N2 * Heat-shock 12.84 ± 0.61 19 − 98/140 
daf-16(RNAi) * Heat-shock 9.81 ± 0.32 17 0.0001 102/140
sir-2.4(RNAi) * Heat-shock 9.34 ± 0.19 17 <0.0001 143/176
N2  Heat-shock 15.52 ± 1.02 24 − 116/140
daf-16(RNAi)  Heat-shock 11.70 ± 0.32 20 <0.0001 134/140
sir-2.4(RNAi)  Heat-shock 11.07 ± 0.19 20 <0.0001 163/176
N2  Heat-shock 15.84 ± 0.74 22 − 103/160
daf-16(RNAi)  Heat-shock 11.70 ± 0.68 15 0.0004 118/160
sir-2.4(RNAi)  Heat-shock 10.53 ± 0.41 15 <0.0001 145/196
N2 * H2O2 7.58 ± 0.06 8 − 140/160
daf-16(RNAi) * H2O2 5.33 ± 0.08 5.5 <0.0001 156/160
sir-2.4(RNAi) * H2O2 5.14 ± 0.08 5.5 <0.0001 191/196
N2  H2O2 11.68 ± 0.1 8 − 134/160
daf-16(RNAi)  H2O2 5.81 ± 0.06 5 <0.0001 152/160
sir-2.4(RNAi)  H2O2 5.68 ± 0.10 5 <0.0001 183/196
N2, control Heat-shock 12.01 ± 0.26 13 − 65/72 
N2, cbp-1(RNAi) Heat-shock 9.09 ± 0.32 11 <0.0001 68/72 
N2, control H2O2 11.56 ± 0.22 13 − 72/72 
N2, cbp-1(RNAi) H2O2 7.72 ± 0.16 9 <0.0001 72/72 
N2 * Heat-shock 17.08 ± 0.25 19 − 81/90 
EQ137 (sir-2.4::gfp o/e) * Heat-shock 16.16 ± 0.24 19.2 0.1506 86/86 
N2 * Heat-shock 12.70 ± 0.18 13 − 65/65 
EQ137 (sir-2.4::gfp o/e) Heat-shock 12.16 ± 0.16 14 0.4989 54/72 
N2 * Heat-shock 10.90 ± 0.13 11  36/36 
EQ158 (sir-2.4 o/e) * Heat-shock 11.07 ± 0.16 11.5 0.4654 30/30 
 
 
Table 4. Effects of sir-2.4 expression on stress resistance  
Animals grown on vector control, daf-16 or sir-2.4 RNAi bacteria were exposed to heat or 
oxidative stress. Mean survival ± SEM, in hours, observed in the stress analysis was shown in the 
table. 75th percentile is the time at which the fraction of animals alive reaches 0.25. ‘n’ indicates 
the number of animals scored in the each experiment. P-Values calculated by pair-wise 
comparisons to vector control of the same experiment. We used Stata 8 software for statistical 
analysis and to determine means and percentiles. The logrank (Mantel-Cox) test was used to test 
the hypothesis that the survival functions among groups were equal.  
 
a P-Values calculated by pair-wise comparisons to N2 grown on vector control of the same 
experiment.  
b Compared to N2 grown on the same RNAi bacteria.  
c Compared to the same mutants grown on vector control.  






± SEM (Days) 
75th Percentile 
(Days) 
P Value n 
N2; control 17.57 ± 0.24 24 − 57/60 
N2; sir-2.4(RNAi) 18.87 ± 0.55 24 0.0638a 73/75 
daf-2(e1370); control 50.23 ± 0.91 63 <0.0001a 64/90 
daf-2(e1370); sir-2.4(RNAi) 48.43 ± 0.61 60 <0.0001a, 0.5428b 68/90 
N2; control 20.16 ± 1.03 23 − 48/59 
N2; cbp-1(RNAi) 5.79 ± 0.42 7 <0.0001a 54/60 
sir-2.4(n5137); control 18.15 ± 1.15 23 0.1988a 50/71 




N2 16.51 ± 0.72 20 − 63/72 
EQ137 (sir-2.4::gfp o.e.) 17.85 ± 0.66 22 0.1318 53/72 
N2 20.18 ± 0.62 23 − 61/72 





Figure 29: SIR-2.4::GFP translational fusion construct was made by Dr. Bo Yang in Dr. 
David Lombard’s lab. 
Table 5. Effects of sir-2.4 expression on lifespan  
Adult mean lifespan ± SEM, in days, observed in lifespan analyses. Lifespan experiments were 
carried out at 20°C. 75th percentile is the age at which the fraction of animals alive reaches 0.25. 
‘n’ shows the number of observed deaths relative to total number of animals started at day 1. The 
difference between these numbers represents the number of animals censored during the 
experiment, and includes animals that exploded, bagged (i.e. exhibited internal progeny 
hatching), or crawled off the plates.  
 
a p-Values calculated by pair-wise comparisons to N2 control of the same experiment.  
b p-Values calculated by pair-wise comparisons to mutants fed with control bacteria of the same 
experiment.  
c p- Values calculated by pair-wise comparisons to N2 fed with the same RNAi bacteria of the 
same experiment. We used Stata 8 software for statistical analysis and to determine means and 
percentiles. The logrank (Mantel-Cox) test was used to test the hypothesis that the survival 
functions among groups were equal. 
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Figure 31D: DAF-16/SIR-2.4 co-immunoprecipitation was performed by Dr. Daniel 
Tishkoff in Dr. David Lombard’s lab. 
Figure 33 E: in vitro CBP-1 acetylation assay was performed by Dr. Daniel Tishkoff in Dr. 
David Lombard’s lab. 
Mass-spec identification of DAF-16 acetylation sites was performed by Dr. Joshua 







Chapter 4.  Conclusions 
 
4-1 DDL-1 and DDL-2 as negative regulators of HSF-1 
Heat-shock response is the universal and fundamental mechanism for cell protection 
against heat stress. The most important feature of the heat-shock response is the 
elevated expression of heat-shock proteins (HSPs), which is regulated by heat-shock 
factor (HSF). Multiple mechanisms have been shown to tightly control HSF activity to 
ensure fine-tuned expression of the heat-shock responsive genes. Multi-chaperone 
complex, a heat-sensitive protein complex, was previously known to inhibit HSF-1 
activity through assembling HSF-1 into a heterocomplex, thereby preventing subsequent 
HSF-1 activation. In this study, we revealed that two novel HSF-1 regulators, DDL-1 and 
DDL-2, modulate longevity and stress response. Our data strongly suggested that DDL-1, 
DDL-2, HSB-1, and HSF-1 form a distinct heat-insensitive heterocomplex (DHIC) that 
negatively regulates the activation of HSF-1. 
 
Although we found DDL-1 and DDL-2 as novel negative regulators of HSF-1, it is unclear 
whether DDL-1 and DDL-2 act in a tissue-specific manner to modulate HSF-1 activity. 
Future work will aim to create transgenic worms overexpressing DDL-1 or DDL-2 shRNA 
driven by tissue-specific promoter, and the requirement of DDL-1/2 in specific tissue will 
be examined by lifespan or stress resistance assays. The overlapping expression 
pattern among HSF-1, HSB-1, and DDL-1 supports the idea that these proteins interact 
in the same tissue. However, the expression pattern of DDL-2 does not entirely overlap 
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other DHIC components. It is not clear whether DDL-2 in those non-overlapping tissues 
plays a role in HSF-1 regulation. Thus, future work will also aim to elucidate whether 
DDL-2 acts in those non-overlapping tissues to specify longevity and stress resistance. 
Overall, in this study, we revealed crucial roles for two novel HSF-1 regulators, DDL-1 
and DDL-2, in attenuation of HSF-1 activity and provided a novel mechanism by which 
HSF-1 activity is controlled.  
 
4-2 Insulin/IGF-like signaling modulates HSF-1 activity though DHIC complex 
HSF-1 has long been implicated as playing a critical role in the insulin/IGF-like signaling 
pathway, as the increased longevity observed in many of the DAF-2 pathway mutants 
requires hsf-1. Previous reports have shown that optimal expression of a subset of 
longevity genes downstream of insulin/IGF-like signaling requires both DAF-16 and 
HSF-1, indicating that HSF-1 may act in concert with DAF-16 to mediate the longevity of 
daf-2 mutants. Although the role of HSF-1 in regulating longevity and stress response 
has been previously described, evidence of HSF-1 regulation by insulin/IGF-like 
signaling is incomplete. Our study has shown for the first time that HSF-1 is indeed 
subjected to direct regulation by the insulin/IGF-like signaling, and this regulation occurs 
through the modulation of DHIC formation. 
 
DHIC links insulin/IGF-like signaling to HSF-1. Our data showed that the formation of 
DHIC is diminished when DAF-2 signaling is inactivated by RNAi (Figure 20D), strongly 
suggesting that the insulin/IGF-like signaling modulates the formation of DHIC. Moreover, 
we also found that the overall level of DDL-1 threonine phosphorylation appeared to be 
negatively regulated by DAF-2 activity (Figure 20C). The formation of DHIC is affected 
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by the phosphorylation status of DDL-1, as the threonine-to-alanine mutation at T182 of 
DDL-1 strongly enhanced the binding between HSF-1 and DDL-1 (Figure 20E). Together, 
these results suggested a model in which insulin/IGF-like signaling regulates HSF-1 
activity through the modulation of DDL-1 phosphorylation, which in turn affects the 
formation of DHIC, resulting in a change in the level of heat-susceptible/inducible HSF-1. 
Together, our proposed model provides a novel mechanism by which DHIC links 
insulin/IGF-like signaling to heat-shock response (Figure 24). 
 
Although our biochemical evidence have suggested a disruption of DHIC formation upon 
reduced insulin/IGF-like signaling (Figure 20D), the in vivo molecular detail of this 
process remains unclear and should be explored in the future. While the in vivo 
interaction between DDL-1 and HSB-1 has been confirmed by BiFC (Figure 19), other 
interactions among DHIC components are not verified in vivo. To further validate DHIC 
complex formation, we will create transgenic worms expressing all combinations of 
DDL-1, DDL-2, and HSB-1 proteins tagged with fluorescent protein (VN173/VC155) 
fragments, and examine protein-protein interactions by BiFC. However, an optimized 
fusion protein pair for BiFC should be carefully designed. The distance and sterical 
orientation of the interaction partners within the complex are not predictable and would 
greatly affect the chances for protein fragments to come together. Thus, in order to 
detect the interaction among DHIC components in vivo, it may be necessary to create all 
possible combinations of N- or C- terminal fusions and optimize the length of polypeptide 
linker between the protein and BiFC fragment.  
 
As shown in Figure 22, DDL-1 T182A mutation minimally impacts DAF-2 longevity, 
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indicating that phosphorylation on T182 may only partially contribute to DAF-2-mediated 
HSF-1 regulation. The insulin/IGF-like signaling may modulate DHIC formation through 
parallel mechanisms. Thus, to determine whether DHIC formation may be regulated by 
other parallel pathways, an optimized DDL-1-HSF-1 BiFC system may also be used for a 
genetic screen to identify novel genes that modulate DHIC formation. 
 
Our observation indicated that the phosphorylation of DDL-1 may play a key role in the 
regulation of DHIC formation; however, the identity of the protein(s) that modulate DDL-1 
phosphorylation is unclear. Although DDL-1 is predicted to be phosphorylated by GSK3 
kinase, inactivation of both GSK-3α and GSK-3β did not alter the phosphorylation status 
of DDL-1 (Figure 23). Thus, to identify potential DDL-1 kinase(s) or phosphatase(s), a 
genetic screen for genes that modulate DDL-1 phosphorylation may be performed. We 
may focus on putative kinase/phosphatase genes that have known genetic interactions 
with DHIC components or the insulin/IGF-like signaling pathways. This screen will 
provide insight into the upstream components that control the formation of DHIC. 
 
4-3 The role of DHIC in regulating the level of heat-inducible HSF-1 activity 
The binding of multi-chaperone complex to HSF-1 was shown to prevent HSF-1 
oligomerization and inhibit its subsequent activation. It has been previously 
demonstrated that the assembly of multi-chaperone complexes can be disrupted by 
stress, allowing the oligomerization and activation of HSF-1. The disruption is known to 
play a critical role in the heat induction of HSF-1 activity. On the other hand, our data 
suggested the presence of a separate pool of HSF-1 that forms a complex with DDL-1, 
DDL-2 and HSB-1 (DHIC). This complex appears to be distinct from the multi-chaperone 
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complex, as the formation of DHIC cannot be disrupted by heat stress (Figure 21B). The 
lack of dissociation indicates that HSF-1 molecules present in DHIC may not be 
subjected to activation by heat stress. Thus, the formation of DHIC diminishes the overall 
level of heat-susceptible HSF-1, reduces the expression of stress-responsive genes, and 
consequently impairs the robustness of heat-shock response. We proposed that the 
formation of DHIC may play a crucial role in modifying heat-shock response through 
controlling the level of heat-inducible HSF-1. 
 
Genetic studies in model organisms have indicated that the longevity is usually 
correlated with increased stress resistance against environmental stresses. A decrease 
heat-shock response results in a reduced level of stress-inducible HSPs, leading to an 
impaired protein homeostasis capacity to withstand the damage caused by cellular 
stress. This impairment has been shown to be associated with age-dependent mortality. 
Recent studies indicated that heat-shock response might play a crucial role in longevity 
regulation. Since HSF is a known central determinant of heat-shock response, molecular 
mechanisms that control the level of heat-inducible HSF may be crucial in determining 
the effectiveness of heat-shock response and thereby longevity. In this study, we 
proposed that insulin/IGF-like signaling controls the level of heat-inducible HSF-1 via the 
modulation of DHIC formation, revealing a novel mechanism by which heat-shock 
response may be fine-tuned by a longevity signaling pathway.  
 
While the role of HSF-1 in the regulation of stress response, longevity, and protein 
homeostasis has been described, whether and how the activity of HSF-1 is modulated by 
hormonal cues is previously unknown. Our study presented here provides better 
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understanding of molecular mechanism underlying the regulation of HSF-1 by the 
insulin/IGF-like signaling pathway. This study could provide invaluable insights into the 
molecular mechanisms that control aging and aid the development of therapeutic 
strategies for age-related diseases. 
 
4-4 SIR-2.4 plays a key role in stress resistance and stress-induced DAF-16 
nuclear translocation 
Sirtuins are important regulators of metabolism, longevity, and stress resistance in 
diverse species. It has been previously reported that sirtuins modulate FoxO activity 
through diverse means. In this work, we revealed a crucial role for C. elegans SIR-2.4, a 
mammalian SIRT6/7 homolog, in promoting stress resistance and the onset of DAF-16 
nuclear translocation in response to stress. SIR-2.4 inactivation rendered animals 
sensitive to both oxidative and heat stress in a daf-16-dependent manner (Figure 28A 
and B). The deletion of sir-2.4 led to a delayed onset of stress-induced DAF-16 nuclear 
accumulation (Figure 26D and E) but did not prevent DAF-16 nuclear recruitment after 
prolonged stress exposure, indicating that SIR-2.4 may play a critical role in the initiation 
or the kinetics of stress-induced DAF-16 nuclear recruitment. 
 
Based on its tissue expression pattern, the expression level of SIR-2.4 appeared to be 
strong in a subset of neurons and somatic gonad cells (Figure 29). It is possible that 
SIR-2.4 regulates DAF-16 in neurons to affect the production of insulin-like peptides 
such as INS-7, thereby influencing systematic DAF-16 localization and function. 
However, we are not certain whether those tissues are key sites for SIR-2.4 to specify 
stress resistance or DAF-16 function, as SIR-2.4 is also expressed in other tissues at 
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lower levels. Thus, in the future, in order to examine whether SIR-2.4 regulates DAF-16 
function in a cell-autonomous fashion, we plan to selectively inactivate SIR-2.4 in 
specific tissues by creating worms carrying sir-2.4 shRNA transgene driven by 
tissue-specific promoter, and assess the effect of tissue-specific knockdown of SIR-2.4 
on DAF-16 localization and function. 
 
4-5 SIR-2.4 modulates DAF-16 acetylation status through the inhibition of CBP 
As observed in our experiment, the inactivation of sir-2.4 greatly delayed stress-induced 
nuclear translocation of DAF-16 and promoted acetylation of DAF-16, suggesting that 
DAF-16 could be the substrate of SIR-2.4 for deacetylation. However, our in vitro 
deacetylase assay suggested that SIR-2.4 may not deacetylate DAF-16. Indeed, in vivo 
rescue experiments showed that SIR-2.4 catalytic activity is dispensable for DAF-16 
nuclear accumulation during stress (Figure 31E), indicating that SIR-2.4 does not directly 
regulate the localization and function of DAF-16 through its enzymatic activity. Our in 
vitro acetyltransferase assay revealed that SIR-2.4 blocks CBP-1-dependent DAF-16 
acetylation in a catalytic-independent manner (Figure 33E), similar to the role of DEK in 
the inhibition of p300 and PCAF-mediated histone acetylation [131]. Since our 
biochemical assay showed that DAF-16 and SIR-2.4 interact (Figure 31D), we concluded 
that SIR-2.4 prevents CBP-mediated DAF-16 acetylation likely through protein-protein 
interaction. To test our model, future work will aim to examine whether SIR-2.4 inhibits 
DAF-16 acetylation on CBP-1-dependent sites, including K248, K253, K375 and K379, in 
vivo by quantitative mass spectrometry. We will also address whether the interaction 
between SIR-2.4 and DAF-16 is important for preventing CBP-1-dependent acetylation 
of DAF-16 by mapping the interacting domains between SIR-2.4 and DAF-16. The 
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requirement of SIR-2.4/DAF-16 interaction for inhibiting CBP-1-dependent DAF-16 
acetylation can be assessed by creating deletion/truncation mutants of SIR-2.4 followed 
by in vitro acetylatransferase assay. Collectively, our data presented here suggested that 
the antagonistic function of SIR-2.4 and CBP-1 might play a crucial role in regulating 
DAF-16 localization, and non-catalytic functions of sirtuins may play a significant role in 
modulating cellular functions. 
 
4-6 The role of acetylation in DAF-16 nuclear translocation and function 
Despite the acetylation of mammalian FoxOs playing a potent role in modulating their 
localizations, function and other physiological outcomes, the role of DAF-16 acetylation 
in C. elegans was not clear. In this work, we demonstrated for the first time that DAF-16 
is acetylated in worms, and the level of DAF-16 acetylation is modulated by CBP-1 and 
SIR-2.4 (Figure 31A-C and Figure 33B). Inactivation of SIR-2.4 promoted DAF-16 
acetylation and dramatically affected stress-induced nuclear translocation of DAF-16 
(Figure 26D and 21E), whereas cbp-1 RNAi led to a decrease in DAF-16 acetylation 
level and constitutive DAF-16 nuclear accumulation (Figure 33A) These results 
suggested that DAF-16 acetylation may prevent its nuclear accumulation. Moreover, our 
biochemical evidence showed that DAF-16 can be directly acetylated by CBP-1 in vitro 
at four lysine residues: K248, K253, K375, and K379. Thus, modulation of DAF-16 
acetylation status may be crucial for proper DAF-16 localization, target gene expression, 
and organismal survival upon stress. To understand whether the acetylation of these 
lysine residues plays a key role in DAF-16 localization and function, we plan to perform 
site-directed mutagenesis on acetylated lysine residues to assess the functional impact 
of acetylation on DAF-16 localization and function. We will create transgenic animals 
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carrying DAF-16::GFP array on which these lysine residues are mutated to arginine (K to 
R) or glutamate (K to Q) to mimic deacetylation or acetylation, respectively. These 
transgenic lines will be analyzed for stress-dependent DAF-16 nuclear translocation, 
DAF-16-dependent gene expression, stress resistance, and longevity.  
 
While our data suggested that the modulation of DAF-16 acetylation by CBP-1 and 
SIR-2.4 may play a crucial role in regulating DAF-16 localization and function, it is likely 
that other acetyltransferases and deacetylases may also participate in this regulation. As 
shown previously, the inactivation of CBP-1 led to a modest decrease in the level of 
acetylated DAF-16 but did not completely eliminate DAF-16 acetylation, indicating that 
DAF-16 is a target of other acetyltransferases. On the other hand, according to our 
model, if SIR-2.4 prevents CBP-1-dependent DAF-16 acetylation in a deacetylase 
activity-independent fashion, another protein(s) has to be present in order to deacetylate 
DAF-16. Thus, future plans will aim to characterize other DAF-16 deacetylases and 
acetyltransferases and examine their functions in DAF-16 regulation. There are at least 
nine potential protein acetyltransferases (including cbp-1, pcaf-1, mys-1,-2 and -4) and 
twelve protein deacetylases (including sir-2.1 to sir-2.4) encoded in C. elegans genome. 
To fully characterize DAF-16 deacetylases and acetyltransferases, we will test whether 
the inactivation of these candidate genes affects DAF-16 acetylation and examine 
functional impact of these genes on DAF-16 nuclear translocation and function, under 
basal and stress conditions. Once the DAF-16 deacetylases and acetyltransferases are 





4-7 Final remark: Cross-talk between the insulin/IGF-like signaling and stress 
response pathways 
Regulation of the insulin/IGF-like signaling and stress response pathways plays a crucial 
role in aging and longevity assurance. Stress resistance is found to be a general feature 
of many long-lived mutant animals, while the expression of many stress-responsive 
genes has been shown to promote longevity [2,40,132]. These observations imply that 
the insulin/IGF-like signaling and stress response pathways are closely linked, and 
cross-talks between these pathways are very likely to coordinate the physiological 
process that control longevity in many systems. 
 
Stress has a known role in influencing the activity of the insulin/IGF-like signaling 
pathway. In worms, it has been shown that environmental stress (e.g. starvation or 
elevated temperature) leads to a reduction in DAF-2 signaling and alters many 
physiological pathways through modulating DAF-16. In mammals, stress signals are 
known to modulate the activity of several components of insulin signaling. For instance, it 
has been shown that endogenous redox levels play both positive and negative roles in 
modulating insulin receptor autophosphorylation [133]. Moreover, PTEN is shown to be 
inactivated by oxidative conditions through altering disulfide bond formation within its 
catalytic site [134]. These data indicate that stress signals can alter the activity of the 
insulin/IGF-like signaling pathway. 
 
Moreover, multiple types of stressors, including heat-shock, oxidative stress, and heavy 
metals are known to modulate FoxO/DAF-16 activity in parallel to the insulin/IGF-like 
signaling. For instance, c-Jun N-terminal kinase (JNK), Ste20-like protein kinase MST1, 
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and B55α regulatory subunit of protein phosphatase 2A (PP2A) are reported to promote 
nuclear translocation and activation of DAF-16/FoxO in response to stress. [47,49,93]. 
DAF-16/FoxO can also be modulated by other stress-induced PTMs including 
acetylation [42-45], mono-ubiquitylation [46], and methylation [51]. In this study, we 
proposed that SIR-2.4 promotes stress-induced DAF-16 nuclear translocation and 
function via preventing CBP-1-dependent DAF-16 acetylation (Figure 34), providing a 
unique, novel mechanism by which sirtuins regulate DAF-16/FoxO.  
 
On the other hand, insulin/IGF-like signaling regulates stress response through 
modulating certain components of stress signaling pathways. In worms, SKN-1, an 
ortholog of mammalin Nrf transcription factor that drives the expression of Phase 2 
detoxification genes in response to stress [135], is known to be regulated by the p38 
MAPK pathway [136]. SKN-1 was considered to be an integral part of stress signaling; 
however, it has been recently found that SKN-1 can also be directly regulated by 
insulin/IGF-like signaling. It was shown that DAF-2 inhibits nuclear accumulation and 
downstream gene expression of SKN-1 through AKT-1/2- and SGK-1-dependent 
phosphorylation [137]. Similarly, our work here showed that HSF-1, a transcription factor 
previously known to function primarily in stress response, is also subject to regulation by 
insulin/IGF-like signaling. The regulation of HSF-1 by insulin/IGF-like signaling occurs 
through the modulation of the formation of DHIC, a protein complex that contains HSF-1, 
DDL-1, DDL-2, and HSB-1. This study revealed a potential mechanism by which 
insulin/IGF-like signaling modulates heat shock response through fine-tuning the level of 
heat-susceptible/inducible HSF-1, and provides a new link between insulin/IGF-like 




The insulin/IGF-like signaling and stress response pathways are distinct but functionally 
intertwined biological processes; however, our understanding with regard to the 
interactions between these pathways is still incomplete. The studies presented in this 
thesis have provided potential mechanisms at the molecular level that link these 
pathways together. Since most of the components of insulin/IGF-like signaling and stress 
response pathways are largely homologous, the cross-talk between these pathways 
could be important for specifying optimum longevity and stress resistance in higher 
organisms, including humans. As a model organism, C. elegans is unique, inexpensive, 
and powerful for studying systemic regulation of longevity and stress response, as 
similar studies in mammals can be laborious and extremely expensive. Findings 
obtained in worms will provide important insights into how these pathways are regulated 
in organismal level. Therefore, future studies focusing on cross-talks between 
insulin/IGF-like signaling and stress response pathways in worms will shed light on the 
mechanisms by which the aging process and stress response are controlled, and 
provide new insights for developing future pharmacological interventions to promote 
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